Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin
Modified by
  • Commission Regulation (EEC) No 675/92of 18 March 1992amending Annexes I and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 392R0675, March 19, 1992
  • Commission Regulation (EEC) No 762/92of 27 March 1992modifying Annex V to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 392R0762, March 28, 1992
  • Commission Regulation (EEC) No 3093/92of 27 October 1992amending Annex III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 392R3093, October 28, 1992
  • Commission Regulation (EEC) No 895/93of 16 April 1993amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 393R0895, April 17, 1993
  • Council Regulation (EEC) No 2901/93of 18 October 1993amending Annexes I, II, III and IV to Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 393R2901, October 23, 1993
  • Commission Regulation (EC) No 3425/93of 14 December 1993amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 393R3425, December 15, 1993
  • Commission Regulation (EC) No 3426/93of 14 December 1993amending Annexes III and IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 393R3426, December 15, 1993
  • Commission Regulation (EC) No 955/94of 28 April 1994amending Annexes I and II of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 394R0955, April 29, 1994
  • Commission Regulation (EC) No 1430/94of 22 June 1994amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 394R1430, June 23, 1994
  • Commission Regulation (EC) No 2703/94of 7 November 1994amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 394R2703, November 8, 1994
  • Commission Regulation (EC) No 2701/94of 7 November 1994amending Annexes I, II, III and IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 394R2701, November 8, 1994
  • Commission Regulation (EC) No 3059/94of 15 December 1994amending Annexes I, II, and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 394R3059, December 16, 1994
  • Commission Regulation (EC) No 1102/95of 16 May 1995amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 395R1102, May 17, 1995
  • Commission Regulation (EC) No 1441/95of 26 June 1995amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 395R1441, June 27, 1995
  • Commission Regulation (EC) No 1442/95of 26 June 1995amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance) Corrigendum to Commission Regulation (EC) No 1442/95 of 26 June 1995 amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Official Journal of the European Communities No L 143 of 27 June 1995) Corrigendum to Commission Regulation (EC) No 1442/95 of 26 June 1995 amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Official Journal of the European Communities No L 143 of 27 June 1995) Corrigendum to Commission Regulation (EC) No 1442/95 of 26 June 1995 amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Com munity procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Official journal of the European Communities No L 143 of 27 June 1995), 395R1442395R1442R(02)395R1442R(03)395R1442R(04), June 27, 1995
  • Commission Regulation (EC) No 1798/95of 25 July 1995amending Annex IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 395R1798, July 26, 1995
  • Commission Regulation (EC) No 2796/95of 4 December 1995amending Annex II of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance) Corrigendum to Commission Regulation (EC) No 2796/95 of 4 December 1995 amending Annex II of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Official Journal of the European Union L 290 of 5 December 1995), 395R2796395R2796R(01), December 5, 1995
  • Commission Regulation (EC) No 2804/95of 5 December 1995amending Annex II of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 395R2804, December 6, 1995
  • Commission Regulation (EC) No 282/96of 14 February 1996amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 396R0282, February 15, 1996
  • Commission Regulation (EC) No 281/96of 14 February 1996amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 396R0281, February 15, 1996
  • Commission Regulation (EC) No 1147/96of 25 June 1996amending Annexes II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 396R1147, June 26, 1996
  • Commission Regulation (EC) No 1140/96of 25 June 1996amending Annex III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 396R1140, June 26, 1996
  • Commission Regulation (EC) No 1311/96of 8 July 1996amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 396R1311, July 9, 1996
  • Commission Regulation (EC) No 1312/96of 8 July 1996amending Annex III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 396R1312, July 9, 1996
  • Commission Regulation (EC) No 1433/96of 23 July 1996amending Annexes II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 396R1433, July 24, 1996
  • Commission Regulation (EC) No 1742/96of 6 September 1996amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 396R1742, September 7, 1996
  • Commission Regulation (EC) No 1798/96of 17 September 1996amending Annex III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 396R1798, September 18, 1996
  • Commission Regulation (EC) No 2010/96of 21 October 1996amending Annex II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 396R2010, October 22, 1996
  • Commission Regulation (EC) No 2017/96of 22 October 1996amending Annex III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 396R2017, October 23, 1996
  • Commission Regulation (EC) No 2034/96of 24 October 1996amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 396R2034, October 25, 1996
  • Commission Regulation (EC) No 17/97of 8 January 1997amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 397R0017, January 9, 1997
  • Commission Regulation (EC) No 211/97of 4 February 1997amending Annex II of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 397R0211, February 5, 1997
  • Commission Regulation (EC) No 270/97of 14 February 1997amending Annex I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 397R0270, February 15, 1997
  • Council Regulation (EC) No 434/97of 3 March 1997amending Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 397R0434, March 7, 1997
  • Commission Regulation (EC) No 716/97of 23 April 1997amending Annexes II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 397R0716, April 24, 1997
  • Commission Regulation (EC) No 748/97of 25 April 1997amending Annex I and II of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 397R0748, April 26, 1997
  • Commission Regulation (EC) No 749/97of 25 April 1997amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 397R0749, April 26, 1997
  • Commission Regulation (EC) No 1838/97of 24 September 1997amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 397R1838, September 25, 1997
  • Commission Regulation (EC) No 1836/97of 24 September 1997amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 397R1836, September 25, 1997
  • Commission Regulation (EC) No 1837/97of 24 September 1997amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 397R1837, September 25, 1997
  • Commission Regulation (EC) No 1850/97of 25 September 1997amending Annex III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 397R1850, September 26, 1997
  • Commission Regulation (EC) No 121/98of 16 January 1998amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R0121, January 17, 1998
  • Commission Regulation (EC) No 426/98of 23 February 1998amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R0426, February 24, 1998
  • Commission Regulation (EC) No 613/98of 18 March 1998amending Annexes II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R0613, March 19, 1998
  • Commission Regulation (EC) No 1000/98of 13 May 1998amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R1000, May 14, 1998
  • Commission Regulation (EC) No 1076/98of 27 May 1998amending Annex II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R1076, May 28, 1998
  • Commission Regulation (EC) No 1191/98of 9 June 1998amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R1191, June 10, 1998
  • Commission Regulation (EC) No 1568/98of 17 July 1998amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance) Corrigendum to Commission Regulation (EC) No 1568/98 of 17 July 1998 amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Official Journal of the European Communities L 205 of 22 July 1998), 398R1568398R1568R(01), July 22, 1998
  • Commission Regulation (EC) No 1570/98of 17 July 1998amending Annexes I to IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R1570, July 22, 1998
  • Commission Regulation (EC) No 1569/98of 17 July 1998amending Annexes II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R1569, July 22, 1998
  • Commission Regulation (EC) No 1917/98of 9 September 1998amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R1917, September 10, 1998
  • Commission Regulation (EC) No 1916/98of 9 September 1998amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R1916, September 10, 1998
  • Commission Regulation (EC) No 1958/98of 15 September 1998amending Annexes I, II and III of Council Regulation (EEC) No 2377/94 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R1958, September 16, 1998
  • Commission Regulation (EC) No 2560/98of 27 November 1998amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R2560, November 28, 1998
  • Commission Regulation (EC) No 2686/98of 11 December 1998amending Annexes I and II of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R2686, December 12, 1998
  • Commission Regulation (EC) No 2692/98of 14 December 1998amending Annex II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R2692, December 15, 1998
  • Commission Regulation (EC) No 2728/98 of17 December 1998amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 398R2728, December 18, 1998
  • Commission Regulation (EC) No 508/1999of 4 March 1999amending Annexes I to IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin Corrigendum to Commission Regulation (EC) No 508/1999 of 4 March 1999 amending Annexes I to IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Official Journal of the European Communities L 60 of 9 March 1999), 399R0508399R0508R(01), March 9, 1999
  • Commission Regulation (EC) No 804/1999of 16 April 1999amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R0804, April 17, 1999
  • Commission Regulation (EC) No 953/1999of 5 May 1999amending Annexes II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R0953, May 6, 1999
  • Commission Regulation (EC) No 954/1999of 5 May 1999amending Annex III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R0954, May 6, 1999
  • Commission Regulation (EC) No 997/1999of 11 May 1999amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R0997, May 12, 1999
  • Commission Regulation (EC) No 998/1999of 11 May 1999amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R0998, May 12, 1999
  • Council Regulation (EC) No 1308/1999of 15 June 1999amending Regulation (EC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin Corrigendum to Council Regulation (EC) No 1308/1999 of 15 June 1999 amending Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Official Journal of the European Communities L 156 of 23 June 1999), 399R1308399R1308R(01), June 23, 1999
  • Commission Regulation (EC) No 1931/1999of 9 September 1999amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R1931, September 10, 1999
  • Commission Regulation (EC) No 1942/1999of 10 September 1999amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R1942, September 11, 1999
  • Commission Regulation (EC) No 1943/1999of 10 September 1999amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R1943, September 11, 1999
  • Commission Regulation (EC) No 2385/1999of 10 November 1999amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R2385, November 11, 1999
  • Commission Regulation (EC) No 2393/1999of 11 November 1999amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R2393, November 12, 1999
  • Commission Regulation (EC) No 2593/1999of 8 December 1999amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R2593, December 9, 1999
  • Commission Regulation (EC) No 2728/1999of 20 December 1999amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R2728, December 22, 1999
  • Commission Regulation (EC) No 2757/1999of 22 December 1999amending Annexes I and II of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R2757, December 23, 1999
  • Commission Regulation (EC) No 2758/1999of 22 December 1999amending Annex II of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 399R2758, December 23, 1999
  • Commission Regulation (EC) No 1286/2000of 19 June 2000amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 300R1286, June 20, 2000
  • Commission Regulation (EC) No 1295/2000of 20 June 2000amending Annexes II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 300R1295, June 21, 2000
  • Commission Regulation (EC) No 1960/2000of 15 September 2000amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 300R1960, September 16, 2000
  • Commission Regulation (EC) No 2338/2000of 20 October 2000amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 300R2338, October 21, 2000
  • Commission Regulation (EC) No 2391/2000of 27 October 2000amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 300R2391, October 28, 2000
  • Commission Regulation (EC) No 2535/2000of 17 November 2000amending Annex I of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 300R2535, November 18, 2000
  • Commission Regulation (EC) No 2908/2000of 29 December 2000amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 300R2908, December 30, 2000
  • Commission Regulation (EC) No 749/2001of 18 April 2001amending Annex II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 301R0749, April 19, 2001
  • Commission Regulation (EC) No 750/2001of 18 April 2001amending Annex II to Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 301R0750, April 19, 2001
  • Commission Regulation (EC) No 807/2001of 25 April 2001amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance) Corrigendum to Commission Regulation (EC) No 807/2001 of 25 April 2001 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Official Journal of the European Communities L 118 of 27 April 2001), 301R0807301R0807R(01), April 27, 2001
  • Commission Regulation (EC) No 1274/2001of 27 June 2001amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 301R1274, June 28, 2001
  • Commission Regulation (EC) No 1322/2001of 29 June 2001amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 301R1322, June 30, 2001
  • Commission Regulation (EC) No 1478/2001of 18 July 2001amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 301R1478, July 19, 2001
  • Commission Regulation (EC) No 1553/2001of 30 July 2001amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 301R1553, July 31, 2001
  • Commission Regulation (EC) No 1680/2001of 22 August 2001amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 301R1680, August 23, 2001
  • Commission Regulation (EC) No 1815/2001of 14 September 2001amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance) Corrigendum to Commission Regulation (EC) No 1815/2001 of 14 September 2001 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Official Journal of the European Communities L 246 of 15 September 2001), 301R1815301R1815R(01), September 15, 2001
  • Commission Regulation (EC) No 1879/2001of 26 September 2001amending Annex II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 301R1879, September 27, 2001
  • Commission Regulation (EC) No 2162/2001of 7 November 2001amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 301R2162, November 8, 2001
  • Council Regulation (EC) No 2584/2001of 19 December 2001amending Annexes I and III of Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 301R2584, December 29, 2001
  • Commission Regulation (EC) No 77/2002of 17 January 2002amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 302R0077, January 18, 2002
  • Commission Regulation (EC) No 869/2002of 24 May 2002amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 302R0869, May 25, 2002
  • Commission Regulation (EC) No 868/2002of 24 May 2002amending Annexes I and II of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 302R0868, May 25, 2002
  • Commission Regulation (EC) No 1181/2002of 1 July 2002amending Annex I of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance) Corrigendum to Commission Regulation (EC) No 1181/2002 of 1 July 2002 amending Annex I of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Official Journal of the European Communities L 172 of 2 July 2002) Corrigendum to Commission Regulation (EC) No 1181/2002 of 1 July 2002 amending Annex I of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Official Journal of the European Communities L 172 of 2 July 2002) Corrigendum to Commission Regulation (EC) No 1181/2002 of 1 July 2002 amending Annex I of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Official Journal of the European Communities L 172 of 2 July 2002), 302R1181302R1181R(01)302R1181R(02)302R1181R(03), July 2, 2002
  • Commission Regulation (EC) No 1530/2002of 27 August 2002amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 302R1530, August 28, 2002
  • Commission Regulation (EC) No 1752/2002of 1 October 2002amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 302R1752, October 2, 2002
  • Commission Regulation (EC) No 1937/2002of 30 October 2002amending Annexes II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 302R1937, October 31, 2002
  • Commission Regulation (EC) No 61/2003of 15 January 2003amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 303R0061, January 16, 2003
  • Commission Regulation (EC) No 544/2003of 27 March 2003amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 303R0544, March 28, 2003
  • Commission Regulation (EC) No 665/2003of 11 April 2003amending Annex III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 303R0665, April 12, 2003
  • Commission Regulation (EC) No 739/2003of 28 April 2003amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 303R0739, April 29, 2003
  • Council Regulation (EC) No 806/2003of 14 April 2003adapting to Decision 1999/468/EC the provisions relating to committees which assist the Commission in the exercise of its implementing powers laid down in Council instruments adopted in accordance with the consultation procedure (qualified majority), 303R0806, May 16, 2003
  • Commission Regulation (EC) No 1029/2003of 16 June 2003amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 303R1029, June 17, 2003
  • Commission Regulation (EC) No 1490/2003of 25 August 2003amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 303R1490, August 26, 2003
  • Commission Regulation (EC) No 1873/2003of 24 October 2003amending Annex II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 303R1873, October 25, 2003
  • Commission Regulation (EC) No 2011/2003of 14 November 2003amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 303R2011, November 15, 2003
  • Commission Regulation (EC) No 2145/2003of 8 December 2003amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 303R2145, December 9, 2003
  • Commission Regulation (EC) No 324/2004of 25 February 2004amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 304R0324, February 26, 2004
  • Commission Regulation (EC) No 546/2004of 24 March 2004amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 304R0546, March 25, 2004
  • Commission Regulation (EC) No 1101/2004of 10 June 2004amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance) Corrigendum to Commission Regulation (EC) No 1101/2004 of 10 June 2004 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Official Journal of the European Union L 211 of 12 June 2004), 304R1101304R1101R(01), June 12, 2004
  • Commission Regulation (EC) No 1646/2004of 20 September 2004amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance) Corrigendum to Commission Regulation (EC) No 1646/2004 of 20 September 2004 amending Annex I of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Official Journal of the European Union L 296 of 21 September 2004), 304R1646304R1646R(02), September 21, 2004
  • Commission Regulation (EC) No 1851/2004of25 October 2004amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits for veterinary medicinal products in foodstuffs of animal origin(Text with EEA relevance), 304R1851, October 26, 2004
  • Commission Regulation (EC) No 1875/2004of 28 October 2004amending Annexes II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin as regards sodium salicylate and fenvalerate(Text with EEA relevance), 304R1875, October 29, 2004
  • Commission Regulation (EC) No 2232/2004of 23 December 2004amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards altrenogest, beclomethasone dipropionate, cloprostenol, r-cloprostenol, sorbitan sesquioleate and toltrazuril(Text with EEA relevance), 304R2232, December 24, 2004
  • Commission Regulation (EC) No 75/2005of 18 January 2005amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin as regards moxidectin, linear alkyl benzene sulphonic acids with alkyl chain lengths ranging from C9 to C13, containing less than 2,5 % of chains longer than C13 and Acetylisovaleryltylosin(Text with EEA relevance), 305R0075, January 19, 2005
  • Commission Regulation (EC) No 712/2005of 11 May 2005amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin as regards lasalocid and ammonium and sodium salts of bituminosulfonates(Text with EEA relevance), 305R0712, May 12, 2005
  • Commission Regulation (EC) No 869/2005of 8 June 2005amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin as regards ivermectin and carprofen(Text with EEA relevance), 305R0869, June 9, 2005
  • Commission Regulation (EC) No 1148/2005of 15 July 2005amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards penethamate(Text with EEA relevance), 305R1148, July 16, 2005
  • Commission Regulation (EC) No 1299/2005of 8 August 2005amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards phenoxymethylpenicillin, phoxim, norgestomet and thiamphenicol(Text with EEA relevance), 305R1299, August 9, 2005
  • Commission Regulation (EC) No 1356/2005of 18 August 2005amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards oxolinic acid and morantel(Text with EEA relevance), 305R1356, August 19, 2005
  • Commission Regulation (EC) No 1518/2005of 19 September 2005amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards acetylisovaleryltylosin and fluazuron(Text with EEA relevance), 305R1518, September 20, 2005
  • Commission Regulation (EC) No 1911/2005of 23 November 2005amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards flugestone acetate(Text with EEA relevance), 305R1911, November 24, 2005
  • Commission Regulation (EC) No 6/2006of 5 January 2006amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards dihydrostreptomycin, tosylchloramide sodium and Piceae turiones recentes extractum(Text with EEA relevance), 306R0006, January 6, 2006
  • Commission Regulation (EC) No 205/2006of 6 February 2006amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards toltrazuril, diethylene glycol monoethyl ether and polyoxyethylene sorbitan monooleate(Text with EEA relevance), 306R0205, February 7, 2006
  • Commission Regulation (EC) No 1055/2006of 12 July 2006amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards flubendazole and lasalocid(Text with EEA relevance), 306R1055, July 13, 2006
  • Commission Regulation (EC) No 1231/2006of 16 August 2006amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards ceftiofur and polyoxyethylene sorbitan monooleate and trioleate(Text with EEA relevance), 306R1231, August 17, 2006
  • Commission Regulation (EC) No 1451/2006of 29 September 2006amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards fluazuron, sodium nitrite and peforelin(Text with EEA relevance), 306R1451, September 30, 2006
  • Commission Regulation (EC) No 1729/2006of 23 November 2006amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards firocoxib and triclabendazole(Text with EEA relevance), 306R1729, November 24, 2006
  • Commission Regulation (EC) No 1805/2006of 7 December 2006amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards thiamphenicol, fenvalerate and meloxicam(Text with EEA relevance), 306R1805, December 8, 2006
  • Commission Regulation (EC) No 1831/2006of 13 December 2006amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards Doramectin(Text with EEA relevance), 306R1831, December 14, 2006
  • Commission Regulation (EC) No 287/2007of 16 March 2007amending Annex II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards Ginseng, standardised extracts and preparations thereof(Text with EEA relevance), 307R0287, March 17, 2007
  • Commission Regulation (EC) No 703/2007of 21 June 2007amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards Dihydrostreptomycin and Streptomycin(Text with EEA relevance), 307R0703, June 22, 2007
  • Commission Regulation (EC) No 1064/2007of 17 September 2007amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards Avilamycin(Text with EEA relevance), 307R1064, September 18, 2007
  • Commission Regulation (EC) No 1323/2007of 12 November 2007amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards firocoxib(Text with EEA relevance), 307R1323, November 13, 2007
  • Commission Regulation (EC) No 1353/2007of 20 November 2007amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards Monensin, Lasalocid and Tylvalosin(Text with EEA relevance), 307R1353, November 21, 2007
  • Commission Regulation (EC) No 61/2008of 24 January 2008amending Annex II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards dinoprostone(Text with EEA relevance), 308R0061, January 25, 2008
  • Commission Regulation (EC) No 203/2008of 4 March 2008amending Annex III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards gamithromycin(Text with EEA relevance), 308R0203, March 5, 2008
Corrected by
  • Corrigendum to Commission Regulation (EC) No 1442/95 of 26 June 1995 amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 395R1442R(02), September 20, 1995
  • Corrigendum to Commission Regulation (EC) No 1442/95 of 26 June 1995 amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 395R1442R(03), December 5, 1996
  • Corrigendum to Commission Regulation (EC) No 1442/95 of 26 June 1995 amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Com munity procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 395R1442R(04), March 18, 1997
  • Corrigendum to Commission Regulation (EC) No 2796/95 of 4 December 1995 amending Annex II of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 395R2796R(01), November 28, 2007
  • Corrigendum to Commission Regulation (EC) No 1568/98 of 17 July 1998 amending Annexes I, II, III and IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 398R1568R(01), October 8, 1998
  • Corrigendum to Commission Regulation (EC) No 508/1999 of 4 March 1999 amending Annexes I to IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 399R0508R(01), April 30, 2008
  • Corrigendum to Council Regulation (EC) No 1308/1999 of 15 June 1999 amending Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 399R1308R(01), January 13, 2000
  • Corrigendum to Commission Regulation (EC) No 807/2001 of 25 April 2001 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 301R0807R(01), May 16, 2001
  • Corrigendum to Commission Regulation (EC) No 1815/2001 of 14 September 2001 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 301R1815R(01), October 9, 2001
  • Corrigendum to Commission Regulation (EC) No 1181/2002 of 1 July 2002 amending Annex I of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 302R1181R(01), September 19, 2002
  • Corrigendum to Commission Regulation (EC) No 1181/2002 of 1 July 2002 amending Annex I of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 302R1181R(02), February 19, 2003
  • Corrigendum to Commission Regulation (EC) No 1181/2002 of 1 July 2002 amending Annex I of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 302R1181R(03), March 6, 2003
  • Corrigendum to Commission Regulation (EC) No 1101/2004 of 10 June 2004 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 304R1101R(01), November 13, 2004
  • Corrigendum to Commission Regulation (EC) No 1646/2004 of 20 September 2004 amending Annex I of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, 304R1646R(02), December 22, 2004
Council Regulation (EEC) No 2377/90of 26 June 1990laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin THE COUNCIL OF THE EUROPEAN COMMUNITIES, Having regard to the Treaty establishing the European Economic Community, and in particular Article 43 thereof, Having regard to the proposal from the CommissionOJ No C 61, 10. 3. 1989. p. 5., Having regard to the opinion of the European ParliamentOJ No C 96, 17. 4. 1990, p. 273., Having regard to the opinion of the Economic and Social CommitteeOJ No C 201, 17. 8. 1989, p. 1., Whereas the use of veterinary medicinal products in food-producing animals may result in the presence of residues of foodstuffs obtained from treated animals; Whereas as a result of scientific and technical progress it is possible to detect the presence of residues of veterinary medicines in foodstuffs at ever lower levels; whereas it is therefore necessary to establish maximum residue limits for pharmacologically active substances which are used in veterinary medicinal products in respect of all the various foodstuffs of animal origin, including meat, fish, milk, eggs and honey; Whereas in order to protect public health, maximum residue limits must be established in accordance with generally recognized principles of safety assessment, taking into account any other scientific assessment of the safety of the substances concerned which may have been undertaken by international organizations, in particular the Codex Alimentarius or, where such substances are used for other purposes, by other scientific committees established within the Community; Whereas the use of veterinary medicinal products plays an important part in agricultural production; whereas the establishment of maximum residue levels will facilitate the marketing of foodstuffs of animal origin; Whereas the establishment of different maximum residue levels by Member States may hinder the free movement of foodstuffs and of veterinary medicinal products themselves; Whereas it is therefore necessary to lay down a procedure for the establishment of maximum residue levels of veterinary medicinal products by the Community, following a single scientific assessment of the highest possible quality; Whereas the need for the establishment of maximum residue levels throughout the Community is recognized in the Community rules relating to trade in foodstuffs of animal origin; Whereas provisions must be adopted with a view to the systematic establishment of maximum residue levels for new substances capable of pharmacological action intended for administration to food-producing animals; Whereas arrangements must also be made for the establishment of maximum residue levels for substances which are currently used in veterinary medicines administered to food-producing animals; whereas, however, in view of the complexity of this matter and the large number of substances involved, long transitional arrangements are required; Whereas, after scientific assessment by the Committee for Veterinary Medicinal Products, maximum residue levels must be adopted by a rapid procedure which ensures close cooperation between the Commission and the Member States through the Committee set up under Council Directive 81/852/EEC of 28 September 1981 on the approximation of the laws of the Member States relating to analytical, pharmaco-toxicological and clinical standards and protocols in respect of the testing of veterinary medicinal productsOJ No L 317, 6. 11. 1981, p. 16., as last amended by Directive 87/20/EECOJ No L 15, 17. 1. 1987, p. 34.; whereas an urgent procedure is also required to ensure the swift review of any tolerance which might prove insufficient to protect public health; Whereas medicinally induced immunological responses are usually indistinguishable from those which arise naturally, and do not affect consumers of food of animal origin; Whereas the information necessary to assess the safety of residues should be presented in accordance with the principles laid down by Directive 81/852/EEC, HAS ADOPTED THIS REGULATION:
Article 1 1. For the purposes of this Regulation, the following definitions shall apply: (a)"residues of veterinary medicinal products": means all pharmacologically active substances, whether active principles, excipients or degradation products, and their metabolites which remain in foodstuffs obtained from animals to which the veterinary medicinal product in question has been administered; (b)"maximum residue limit": means the maximum concentration of residue resulting from the use of a veterinary medicinal product (expressed in mg/kg or μg/kg on a fresh weight basis) which may be accepted by the Community to be legally permitted or recognized as acceptable in or on a food. It is based on the type and amount of residue considered to be without any toxicological hazard for human health as expressed by the acceptable daily intake (ADI), or on the basis of a temporary ADI that utilizes an additional safety factor. It also takes into account other relevant public health risks as well as food technology aspects.When establishing a maximum residue limit (MRL), consideration is also given to residues that occur in food of plant origin and/or come from the environment. Furthermore, the MRL may be reduced to be consistent with good practices in the use of veterinary drugs and to the extent that practical analytical methods are available. 2. This Regulation shall not apply to active principles of biological origin intended to produce active or passive immunity or to diagnose a state of immunity used in immunological veterinary medicinal products.
Article 2 The list of pharmacologically active substances used in veterinary medicinal products in respect of which maximum residue limits have been established shall be contained in Annex I, which shall be adopted in accordance with the procedure laid down in Article 8. Except as provided for in Article 9, any amendments to Annex I shall be adopted in accordance with the same procedure.
Article 3 Where, following an evaluation of a pharmacologically active substance used in veterinary medicinal products, it appears that it is not necessary for the protection of public health to establish a maximum residue limit, that substance shall be included in a list in Annex II, which shall be adopted in accordance with the procedure laid down in Article 8. Except as provided for in Article 9, any amendments to Annex II shall be adopted in accordance with the same procedure.
Article 4 A provisional maximum residue limit may be established for a pharmacologically active substance used in veterinary medicinal products on the date of entry into force of this Regulation, provided that there are no grounds for supposing that residues of the substance concerned at the level proposed present a hazard for the health of the consumer. A provisional maximum residue limit shall apply for a defined period of time, which shall not exceed five years. That period may be extended once only in exceptional cases for a period not in excess of two years if that proves expedient for the completion of scientific studies in progress. In exceptional circumstances, a provisional maximum residue limit may also be established for a pharmacologically active substance not previously used in veterinary medicinal products on the date of entry into force of this Regulation provided that there are no grounds for supposing that residues of the substance concerned at the limit proposed present a hazard for the health of the consumer. The list of pharmacologically active substances used in veterinary medicinal products in respect of which provisional maximum residue limits have been established shall be contained in Annex III, which shall be adopted in accordance with the procedure laid down in Article 8. Except as provided for in Article 9, any amendments to Annex III shall be adopted in accordance with the same procedure.
Article 5 Where it appears that a maximum residue limit cannot be established in respect of a pharmacologically active substance used in veterinary medicinal products because residues of the substances concerned, at whatever limit, in foodstuffs of animal origin constitute a hazard to the health of the consumer, that substance shall be included in a list in Annex IV, which shall be adopted in accordance with the procedure laid down in Article 8. Except as provided for in Article 9, any amendments to Annex IV shall be adopted in accordance with the same procedure. The administration of the substances listed in Annex IV to food-producing animals shall be prohibited throughout the Community.
Article 6 1. In order to obtain the inclusion in Annexes I, II or III of a pharmacologically active substance which is intended for use in veterinary medicinal products for administration to food-producing animals, an application to establish a maximum residue limit shall be submitted to the European Agency for the Evaluation of Medicinal Products set up by Council Regulation (EEC) No 2309/93OJ L 214, 24.8.1993, p. 1, hereinafter referred to as "the Agency". This application shall contain the information and particulars referred to in Annex V of this Regulation and shall conform with the principles laid down in Directive 81/852/EEC. 2. The application shall also be accompanied by the fee payable to the Agency.
Article 7 1. The Committee for Veterinary Medicinal Products referred to in Article 27 of Regulation (EC) No 2309/93 (hereinafter "the Committee") shall be responsible for formulating the Agency's opinion on the classification of substances referred to in Annexes I, II, III or IV to this Regulation. 2. Articles 52 and 53 of Regulation (EEC) No 2309/93 shall be applicable for the purposes of this Regulation. 3. The Agency shall ensure that the Committee's opinion is delivered within a period of 120 days following the reception of a valid application. If the information submitted by the applicant is not sufficient to enable such an opinion to be prepared, the Committee may ask the applicant to supply additional information within a specific time limit. The deadline for the opinion shall then be deferred until the additional information has been received. 4. The Agency shall forward the opinion to the applicant. Within 15 days of receipt of the opinion, the applicant may provide written notice to the Agency that he wishes to appeal. In that case he shall forward the detailed grounds for his appeal to the Agency within 60 days of receipt of the opinion. Within 60 days of the receipt of the grounds for appeal, the Committee shall consider whether its opinion should be revised and the reasons for the conclusion reached on the appeal shall be annexed to the report referred to in paragraph 5. 5. The Agency shall forward the definitive opinion of the Committee within 30 days of its adoption both to the Commission and to the applicant. The opinion shall be accompanied by a report describing the safety evaluation of the substance by the Committee, which shall give the grounds for its conclusions. 6. The Commission shall prepare draft measures taking account of Community legislation and shall start the procedure provided for in Article 8. The Committee referred to in Article 8 shall adapt its rules of procedure in order to take account of the tasks conferred on it by this Regulation.
Article 8 1. The Commission shall be assisted by the Standing Committee on Veterinary Medicinal Products. 2. Where reference is made to this Article, Articles 5 and 7 of Decision 1999/468/ECOJ L 184, 17.7.1999, p. 23. shall apply. The period laid down in Article 5(6) of Decision 1999/468/EC shall be set at three months. 3. The Standing Committee shall adopt its Rules of Procedure.
Article 9 1. Where a Member State, as a result of new information or a reassessment of existing information, considers that the urgent amendment of a provision contained in Annexes I to IV is necessary in order to protect human or animal health, and therefore requires swift action to be taken, that Member State may temporarily suspend the operation of the provision concerned in its own territory. In that case, it shall immediately notify the other Member States and the Commission of the measures, attaching a statement of the reasons therefor. 2. The Commission shall as soon as possible examine the grounds given by the Member State concerned and, after consulting the Committee for Veterinary Medicinal Products, it shall then deliver its opinion forthwith and take appropriate measures; the person responsible for marketing may be requested to provide the Committee with oral or written explanations. The Commission shall immediately notify the Council and the Member States of any measures taken. Any Member State may refer the Commission's measures to the Council within 15 days of such notification. The Council, acting by a qualified majority, may take a different decision within 30 days of the date on which the matter was referred to it. 3. If the Commission considers that it is necessary to amend the provision of Annex I to IV concerned in order to resolve the difficulties referred to in paragraph 1 and to ensure the protection of human health, it shall initiate the procedure laid down in Article 10 with a view to adopting those amendments; the Member State which has taken measures under paragraph 1 may maintain them until the Council or the Commission has taken a decision in accordance with the abovementioned procedure.
Article 10 1. The Commission shall be assisted by the Standing Committee on Veterinary Medicinal Products. 2. Where reference is made to this Article, Articles 5 and 7 of Decision 1999/468/EC shall apply. The period laid down in Article 5(6) of Decision 1999/468/EC shall be set at 15 days.
Article 11 Any changes which are necessary to adapt Annex V to take account of scientific and technical progress shall be adopted in accordance with the procedure laid down in Article 2c of Directive 81/852/EEC.
Article 12 As soon as possible after the amendment of Annexes I, II, III or IV, the Commission shall publish a summary of the assessment of the safety of the substances concerned that have been examined by the Committee for Veterinary Medicinal Products. The confidential nature of any proprietary data shall be respected. The Agency shall provide the competent authorities and the Commission with appropriate methods for identifying pharmacologically active substances for which the MRL's have been determined in Annexes I and III.
Article 13 Member States may not prohibit or impede the putting into circulation within their territories of foodstuffs of animal origin originating in other Member States on the grounds that they contain residues of veterinary medicinal products if the quantity of residue does not exceed the maximum residue limit provided for in Annex I or III, or if the substance concerned is listed in Annex II.
Article 14 With effect from 1 January 1997, the administration to food-producing animals of veterinary medicinal products containing pharmacologically active substances which are not mentioned in Annexes I, II or III shall be prohibited within the Community, except in the case of clinical trials accepted by the competent authorities following notification or authorization in accordance with the legislation in force and which do not cause foodstuffs obtained from livestock participating in such trials to contain residues which constitute a hazard to human health. However, the date referred to in the previous subparagraph shall be deferred for substances the use of which was authorized on the date of entry into force of this Regulation and in respect of which documented applications for the establishment of maximum residue limits have been lodged with the Commission or with the European Agency for the Evaluation of Medicinal Products before 1 January 1996: until 1 January 1998 in the case of pyrazolinones (including pyrazolidinediones and phenylbutazones), nitroimidazoles and arsalinic acid, and until 1 January 2000 in the case of other substances. The Agency shall publish a list of these substances before 7 June 1997.
Article 15 This Regulation shall in no way prejudice the application of Community legislation prohibiting the use in livestock farming of certain substances having a hormonal action. Nothing in this Regulation shall prejudice the measures taken by Member States to prevent the unauthorized use of veterinary medicinal products.
Article 16 This Regulation shall enter into force on 1 January 1992.
This Regulation shall be binding in its entirety and directly applicable in all Member States. ANNEX I LIST OF PHARMACOLOGICALLY ACTIVE SUBSTANCES FOR WHICH MAXIMUM RESIDUE LIMITS HAVE BEEN FIXED 1.Anti-infectious agents 1.1.Chemotheurapeutics 1.1.1.Sulfonamides
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
All substances belonging to the sulfonamide group Parent drug All food-producing species 100 μg/kg Muscle The combined total residues of all substances within the sulfonamide group should not exceed 100 μg/kg
100 μg/kg Fat
100 μg/kg Liver
100 μg/kg Kidney
Bovine, ovine, caprine 100 μg/kg Milk
1.1.2.Diamino pyrimidine derivatives
For porcine and poultry species this MRL relates to "skin and fat in natural proportions". For fin fish this MRL relates to "muscle and skin in natural proportions".
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Baquiloprim Baquiloprim Bovine 10 μg/kg Fat
300 μg/kg Liver
150 μg/kg Kidney
30 μg/kg Milk
Porcine 40 μg/kg Skin and fat
50 μg/kg Liver
50 μg/kg Kidney
Trimethoprim Trimethoprim All food producing species except equidae 50 μg/kg Fat Not for use in animals from which eggs are produced for human consumption
50 μg/kg Muscle
50 μg/kg Liver
50 μg/kg Kidney
50 μg/kg Milk
Equidae 100 μg/kg Muscle
100 μg/kg Fat
100 μg/kg Liver
100 μg/kg Kidney
1.2.Antibiotics 1.2.1.Penicillins
For intramammary use only. Not for use in animals from which eggs are produced for human consumption.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Amoxicyllin Amoxicyllin All food-producing species 50 μg/kg Muscle
50 μg/kg Fat
50 μg/kg Liver
50 μg/kg Kidney
4 μg/kg Milk
Ampicillin Ampicillin All food-producing species 50 μg/kg Muscle
50 μg/kg Fat
50 μg/kg Liver
50 μg/kg Kidney
4 μg/kg Milk
Benzylpenicillin Benzylpenicillin All food-producing species 50 μg/kg Muscle
50 μg/kg Fat
50 μg/kg Liver
50 μg/kg Kidney
4 μg/kg Milk
Cloxacillin Cloxacillin All food-producing species 300 μg/kg Muscle
300 μg/kg Fat
300 μg/kg Liver
300 μg/kg Kidney
30 μg/kg Milk
Dicloxacillin Dicloxacillin All food-producing species 300 μg/kg Muscle
300 μg/kg Fat
300 μg/kg Liver
300 μg/kg Kidney
30 μg/kg Milk
Nafcillin Nafcillin All ruminants 300 μg/kg Muscle
300 μg/kg Fat
300 μg/kg Liver
300 μg/kg Kidney
30 μg/kg Milk
Oxacillin Oxacillin All food-producing species 300 μg/kg Muscle
300 μg/kg Fat
300 μg/kg Liver
300 μg/kg Kidney
30 μg/kg Milk
Penethamate Benzylpenicillin Bovine 50 μg/kg Muscle
50 μg/kg Fat
50 μg/kg Liver
50 μg/kg Kidney
4 μg/kg Milk
Porcine 50 μg/kg Muscle
50 μg/kg Fat
50 μg/kg Liver
50 μg/kg Kidney
All mammalian-food producing species 50 μg/kg Muscle
50 μg/kg Fat
50 μg/kg Liver
50 μg/kg Kidney
4 μg/kg Milk
Phenoxymethylpenicillin Phenoxymethylpenicillin Porcine 25 μg/kg Muscle
25 μg/kg Liver
25 μg/kg Kidney
Poultry 25 μg/kg Muscle
25 μg/kg Skin + fat
25 μg/kg Liver
25 μg/kg Kidney
1.2.2.Cephalosporins
For porcine species this MRL relates to "skin and fat in natural proportions".
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Cefacetrile Cefacetrile Bovine 125 μg/kg Milk For intramammary use only
Cefalexin Cefalexin Bovine 200 μg/kg Muscle
200 μg/kg Fat
200 μg/kg Liver
1000 μg/kg Kidney
100 μg/kg Milk
Cefalonium Cefalonium Bovine 20 μg/kg Milk
Cefapirin Sum of cephapirin and desacetylcephapirin Bovine 50 μg/kg Muscle
50 μg/kg Fat
100 μg/kg Kidney
60 μg/kg Milk
Cefazolin Cefazolin Bovine, ovine, caprine 50 μg/kg Milk
Cefoperazone Cefoperazone Bovine 50 μg/kg Milk
Cefquinome Cefquinome Bovine 50 μg/kg Muscle
50 μg/kg Fat
100 μg/kg Liver
200 μg/kg Kidney
20 μg/kg Milk
Porcine 50 μg/kg Muscle
50 μg/kg Skin + fat
100 μg/kg Liver
200 μg/kg Kidney
Equidae 50 μg/kg Muscle
50 μg/kg Fat
100 μg/kg Liver
200 μg/kg Kidney
Ceftiofur Sum of all residues retaining the betalactam structure expressed as desfuroylceftiofur All mammalian food-producing species 1000 μg/kg Muscle
2000 μg/kg Fat
2000 μg/kg Liver
6000 μg/kg Kidney
100 μg/kg Milk
1.2.3.Quinolones
For fin fish this MRL relates to "muscle and skin in natural proportions". For porcine species this MRL relates to "skin and fat in natural proportions". Not for use in animals from which milk or eggs are produced for human consumption; MRLs for fat, liver and kidney do not apply to fin fish. For porcine and poultry species this MRL relates to "skin and fat in natural proportions".
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Danofloxacin Danofloxacin All food producing species except bovine, ovine, caprine, porcine and poultry 100 μg/kg Muscle
50 μg/kg Fat
200 μg/kg Liver
200 μg/kg Kidney
Bovine, ovine, caprine 200 μg/kg Muscle
100 μg/kg Fat
400 μg/kg Liver
400 μg/kg Kidney
30 μg/kg Milk
Poultry 200 μg/kg Muscle Not for use in animals from which eggs are produced for human consumption
100 μg/kg Skin and fat
400 μg/kg Liver
400 μg/kg Kidney
Difloxacin Difloxacin All food producing species except bovine, ovine, caprine and poultry 300 μg/kg Muscle
100 μg/kg Fat
800 μg/kg Liver
600 μg/kg Kidney
Bovine, ovine, caprine 400 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
100 μg/kg Fat
1400 μg/kg Liver
800 μg/kg Kidney
Porcine 400 μg/kg Muscle
100 μg/kg Skin and fat
800 μg/kg Liver
800 μg/kg Kidney
Poultry 300 μg/kg Muscle Not for use in animals from which eggs are produced for human consumption
400 μg/kg Skin and fat
1900 μg/kg Liver
600 μg/kg Kidney
Enrofloxacin Sum of enrofloxacin and ciprofloxacin All food producing species except bovine, ovine, caprine, porcine, rabbits and poultry 100 μg/kg Muscle
100 μg/kg Fat
200 μg/kg Liver
200 μg/kg Kidney
Bovine, ovine, caprine 100 μg/kg Muscle
100 μg/kg Fat
300 μg/kg Liver
200 μg/kg Kidney
100 μg/kg Milk
Porcine, rabbits 100 μg/kg Muscle
100 μg/kg Fat
200 μg/kg Liver
300 μg/kg Kidney
Poultry 100 μg/kg Muscle Not for use in animals from which eggs are produced for human consumption
100 μg/kg Skin and fat
200 μg/kg Liver
300 μg/kg Kidney
Flumequine Flumequine All food producing species except bovine, ovine, caprine, porcine, poultry and fin fish 200 μg/kg Muscle
250 μg/kg Fat
500 μg/kg Liver
1000 μg/kg Kidney
Bovine, porcine, ovine, caprine 200 μg/kg Muscle
300 μg/kg Fat
500 μg/kg Liver
1500 μg/kg Kidney
50 μg/kg Milk
Poultry 400 μg/kg Muscle Not for use in animals from which eggs are produced for human consumption
250 μg/kg Skin and fat
800 μg/kg Liver
1000 μg/kg Kidney
Fin fish 600 μg/kg Muscle and skin in natural proportion
Marbofloxacin Marbofloxacin Bovine 150 μg/kg Muscle
50 μg/kg Fat
150 μg/kg Liver
150 μg/kg Kidney
75 μg/kg Milk
Porcine 150 μg/kg Muscle
50 μg/kg Skin and fat
150 μg/kg Liver
150 μg/kg Kidney
Oxolinic acid Oxolinic acid Porcine 100 μg/kg Muscle
50 μg/kg Skin and fat
150 μg/kg Liver
150 μg/kg Kidney
Chicken 100 μg/kg Muscle Not for use in animals from which eggs are produced for human consumption
50 μg/kg Skin and fat
150 μg/kg Liver
150 μg/kg Kidney
Fin fish 100 μg/kg Muscle and skin in natural proportions
All food-producing species 100 μg/kg Muscle
50 μg/kg Fat
150 μg/kg Liver
150 μg/kg Kidney
Sarafloxacin Sarafloxacin Chicken 10 μg/kg Skin and fat
100 μg/kg Liver
Salmonidae 30 μg/kg Muscle and skin in natural proportions
1.2.4.Macrolides
For fin fish this MRL relates to a "muscle and skin in natural proportions". For porcine species this MRL relates to "skin and fat in natural proportions". For porcine and poultry species this MRL relates to "skin and fat in natural proportions". Not for use in animals from which milk is produced for human consumption. Not for use in animals from which milk is produced for human consumption. Not for use in animals from which eggs are produced for human consumption. For poultry species, this MRL relates to "skin and fat in natural proportions".
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Acetylisovaleryltylosin Sum of acetyl-isovaleryltylosin and 3-O-acetyltylosin Porcine 50 μg/kg Muscle
50 μg/kg Skin and fat
50 μg/kg Liver
50 μg/kg Kidney
Poultry 50 μg/kg Skin + fat
50 μg/kg Liver
Erythromycin Erythromicyin A All food producing species 200 μg/kg Muscle
200 μg/kg Fat
200 μg/kg Liver
200 μg/kg Kidney
40 μg/kg Milk
150 μg/kg Eggs
Spiramycin Sum of spiramycin and neospiramycin Bovine 200 μg/kg Muscle
300 μg/kg Fat
300 μg/kg Liver
300 μg/kg Kidney
200 μg/kg Milk
Chicken 200 μg/kg Muscle
300 μg/kg Skin and fat
400 μg/kg Liver
Spiramycin 1 Porcine 250 μg/kg Muscle
2000 μg/kg Liver
1000 μg/kg Kidney
Tilmicosin Tilmicosin All food producing species except poultry 50 μg/kg Muscle
50 μg/kg Fat
1000 μg/kg Liver
1000 μg/kg Kidney
50 μg/kg Milk
Poultry 75 μg/kg Muscle Not for use in animals from which eggs are produced for human consumption
75 μg/kg Sin and fat
1000 μg/kg Liver
250 μg/kg Kidney
Tulathromycin (2R,3S,4R,5R,8R,10R,11R,12S, 13S,14R)-2-ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-ß-D-xylo-hexopy-ranosyl]oxy]-1-oxa-6-azacyclopent-decan-15-one expressed as tulathromycin equivalents Bovine 100 μg/kg Fat
3000 μg/kg Liver
3000 μg/kg Kidney
Porcine 100 μg/kg Skin + fat
3000 μg/kg Liver
3000 μg/kg Kidney
Tylosin Tylosin A All food producing species 100 μg/kg Fat
100 μg/kg Muscle
100 μg/kg Liver
100 μg/kg Kidney
50 μg/kg Milk
200 μg/kg Eggs
Tylvalosin Sum of tylvalosin and 3-O-acetyltylosin Porcine 50 μg/kg Muscle
50 μg/kg Fat
50 μg/kg Liver
50 μg/kg Kidney
Poultry 50 μg/kg Fat
50 μg/kg Liver
1.2.5.Florfenicol and related compounds
Not for use in animals from which eggs are produced for human consumption, MRLs for fat, liver and kidney do not apply to fin fish. For fin fish muscle relates to "muscle and skin in natural proportions". For porcine and poultry species this MRL relates to "skin and fat in natural proportions".
Pharmacologically active Substance(s) Marker residue Animal species MRLs Target tissues
Thiamphenicol Thiamphenicol All food producing species 50 μg/kg Muscle
50 μg/kg Fat
50 μg/kg Liver
50 μg/kg Kidney
50 μg/kg Milk
 1.2.6.Tetracyclines
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Chlortetracycline Sum of parent drug and its 4- epimer All food-producing species 100 μg/kg Muscle
300 μg/kg Liver
600 μg/kg Kidney
100 μg/kg Milk
200 μg/kg Eggs
Doxycycline Doxycycline Bovine 100 μg/kg Muscle
Not for use in animals from which milk is produced for human consumption 300 μg/kg Liver
600 μg/kg Kidney
Porcine 100 μg/kg Muscle
300 μg/kg Skin and fat
300 μg/kg Liver
600 μg/kg Kidney
Poultry 100 μg/kg Muscle
Not for use in animals from which eggs are produced for human consumption 300 μg/kg Skin and fat
300 μg/kg Liver
600 μg/kg Kidney
Oxytetracycline Sum of parent drug and its 4-epimer All food-producing species 100 μg/kg Muscle
300 μg/kg Liver
600 μg/kg Kidney
100 μg/kg Milk
200 μg/kg Eggs
Tetracycline Sum of parent drug and its 4-epimer All food-producing species 100 μg/kg Muscle
300 μg/kg Liver
600 μg/kg Kidney
100 μg/kg Milk
200 μg/kg Eggs
1.2.7.Naphtalene-ringed ansamycin
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Rifaximin Rifaximin Bovine 60 μg/kg Milk
1.2.8.Pleuromutilines
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Tiamulin Sum of metabolites that may be hydrolysed to 8-a-hydroxymutilin Porcine 100 μg/kg Muscle
500 μg/kg Liver
Chicken 100 μg/kg Muscle
100 μg/kg Skin and fat
1000 μg/kg Liver
Rabbits 100 μg/kg Muscle
500 μg/kg Liver
Turkey 100 μg/kg Muscle
100 μg/kg Skin and fat
300 μg/kg Liver
Tiamulin 1000 μg/kg Eggs
Valnemulin Valnemulin Porcine 50 μg/kg Muscle
500 μg/kg Liver
100 μg/kg Kidney
1.2.9.Lincosamides
For porcine and poultry species this MRL relates to "skin and fat in natural proportions". For fin fish this MRL relates to "muscle and skin in natural proportions".
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Lincomycin Lincomicyn All food producing species 50 μg/kg Fat
100 μg/kg Muscle
500 μg/kg Liver
1500 μg/kg Kidney
150 μg/kg Milk
50 μg/kg Eggs
Pirlimycin Pirlimycin Bovine 100 μg/kg Muscle
100 μg/kg Fat
1000 μg/kg Liver
400 μg/kg Kidney
100 μg/kg Milk
Porcine 100 μg/kg Muscle
50 μg/kg Skin and fat
500 μg/kg Liver
1500 μg/kg Kidney
Chicken 100 μg/kg Muscle
50 μg/kg Skin and fat
500 μg/kg Liver
1500 μg/kg Kidney
50 μg/kg Eggs
1.2.10.Aminoglycosides
For porcine and poultry species this MRL relates to "skin and fat in natural proportions". For fin fish this MRL relates to "muscle and skin in natural proportions". Not for use in animals from which eggs are produced for human consumption.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Apramycin Apramycin Bovine 1000 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
1000 μg/kg Fat
10000 μg/kg Liver
20000 μg/kg Kidney
Dihydrostreptomycin Dihydrostreptomycin All ruminants 500 μg/kg Muscle
500 μg/kg Fat
500 μg/kg Liver
1000 μg/kg Kidney
200 μg/kg Milk
Porcine 500 μg/kg Muscle
500 μg/kg Skin + fat
500 μg/kg Liver
1000 μg/kg Kidney
Rabbits 500 μg/kg Muscle
500 μg/kg Fat
500 μg/kg Liver
1000 μg/kg Kidney
Gentamicin Sum of gentamicin C1, gentamicin C1a, gentamicin C2 and gentamicin C2a Bovine 50 μg/kg Muscle
50 μg/kg Fat
200 μg/kg Liver
750 μg/kg Kidney
100 μg/kg Milk
Porcine 50 μg/kg Muscle
50 μg/kg Skin and fat
200 μg/kg Liver
750 μg/kg Kidney
Kanamycin Kanamycin A All food producing species except fish 100 μg/kg Muscle
100 μg/kg Fat
600 μg/kg Liver
2500 μg/kg Kidney
150 μg/kg Milk
Neomycin (including framycetin) Neomycin B All food producing species 500 μg/kg Fat
500 μg/kg Muscle
500 μg/kg Liver
5000 μg/kg Kidney
1500 μg/kg Milk
500 μg/kg Eggs
Paromomycin Paromomycin All food producing species 500 μg/kg Muscle Not for use in animals from which milk or eggs are produced for human consumption
1500 μg/kg Liver
1500 μg/kg Kidney
Spectinomycin Spectinomycin All food producing species except ovine 500 μg/kg Fat Not for use in animals from which eggs are produced for human consumption
300 μg/kg Muscle
1000 μg/kg Liver
5000 μg/kg Kidney
200 μg/kg Milk
Ovine 300 μg/kg Muscle
500 μg/kg Fat
2000 μg/kg Liver
5000 μg/kg Kidney
200 μg/kg Milk
Streptomycin Streptomycin All ruminants 500 μg/kg Muscle
500 μg/kg Fat
500 μg/kg Liver
1000 μg/kg Kidney
200 μg/kg Milk
Porcine 500 μg/kg Muscle
500 μg/kg Skin + fat
500 μg/kg Liver
1000 μg/kg Kidney
Rabbits 500 μg/kg Muscle
500 μg/kg Fat
500 μg/kg Liver
1000 μg/kg Kidney
1.2.11.Other antibiotics
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Novobiocin Novobiocin Bovine 50 μg/kg Milk
1.2.12.Polypeptides
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Bacitracin Sum of bacitracin A, bacitracin B, and bacitracin C Bovine 100 μg/kg Milk
Rabbits 150 μg/kg Muscle
150 μg/kg Fat
150 μg/kg Liver
150 μg/kg Kidney
1.2.13.Beta-lactamase inhibitors
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Clavulanic acid Clavulanic acid Bovine 100 μg/kg Muscle
100 μg/kg Fat
200 μg/kg Liver
400 μg/kg Kidney
200 μg/kg Milk
Porcine 100 μg/kg Muscle
100 μg/kg Skin and fat
200 μg/kg Liver
400 μg/kg Kidney
1.2.14.Polymyxins
For porcine and poultry species this MRL relates to "skin and fat in natural proportions". For fin fish this MRL relates to "muscle and skin in natural proportions".
Pharmacologically active substance Marker residue Animal species MRLs Target tissues Other provisions
Colistin Colistin All food producing species 150 μg/kg Fat
150 μg/kg Muscle
150 μg/kg Liver
200 μg/kg Kidney
50 μg/kg Milk
300 μg/kg Eggs
1.2.15.Orthosomycins
For porcine and poultry species, this MRL relates to skin and fat in natural proportions. Not for use in animals from which eggs are produced for human consumption.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Avilamycin Dichloroisoeverninic acid Porcine 50 μg/kg Muscle
100 μg/kg Fat
300 μg/kg Liver
200 μg/kg Kidney
Rabbit 50 μg/kg Muscle
100 μg/kg Fat
300 μg/kg Liver
200 μg/kg Kidney
Poultry 50 μg/kg Muscle
100 μg/kg Fat
300 μg/kg Liver
200 μg/kg Kidney
 1.2.16.Ionophores
For poultry species, this MRL relates to "skin and fat in natural proportions".
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Monensin Monensin A Bovine 2 μg/kg Muscle
10 μg/kg Fat
30 μg/kg Liver
2 μg/kg Kidney
2 μg/kg Milk
Lasalocid Lasalocid A Poultry 20 μg/kg Muscle
100 μg/kg Fat
100 μg/kg Liver
50 μg/kg Kidney
150 μg/kg Eggs
2.Antiparasitic agents 2.1.Agents acting against endoparasites 2.1.1.Salicylanilides
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Closantel Closantel Bovine 1000 μg/kg Muscle
3000 μg/kg Fat
1000 μg/kg Liver
3000 μg/kg Kidney
Ovine 1500 μg/kg Muscle
2000 μg/kg Fat
1500 μg/kg Liver
5000 μg/kg Kidney
Rafoxanide Rafoxanide Bovine 30 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
30 μg/kg Fat
10 μg/kg Liver
40 μg/kg Kidney
Ovine 100 μg/kg Muscle
250 μg/kg Fat
150 μg/kg Liver
150 μg/kg Kidney
2.1.2.Tatra-hydro-imidazoles (imidazolthiazoles)
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Levamisole Levamisole Bovine, ovine, porcine, poultry 10 μg/kg Muscle
10 μg/kg Fat
100 μg/kg Liver
10 μg/kg Kidney
2.1.3.Benzimidazoles and pro-benzimidazoles
Not for use in animals producing milk for human consumption.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Albendazole Sum of albendazole sulphoxide, albendazole sulphone, and albendazole 2-amino sulphone, expressed as albendazole All ruminants 100 μg/kg Muscle
100 μg/kg Fat
1000 μg/kg Liver
500 μg/kg Kidney
100 μg/kg Milk
Albendazole oxide Sum of albendazole oxide, albendazole sulphone and albendazole 2-aminosulphone, expressed as albendazole Bovine, ovine 100 μg/kg Muscle
100 μg/kg Fat
1000 μg/kg Liver
500 μg/kg Kidney
100 μg/kg Milk
Febantel Sum of extractable residues which may be oxidised to oxfendazole sulphone All ruminants 50 μg/kg Muscle
50 μg/kg Fat
500 μg/kg Liver
50 μg/kg Kidney
10 μg/kg Milk
Fenbendazole Sum of extractable residues which may be oxidised to oxfendazole sulphone All ruminants 50 μg/kg Muscle
50 μg/kg Fat
500 μg/kg Liver
50 μg/kg Kidney
10 μg/kg Milk
Flubendazole Sum of flubendazole and (2-amino 1H-benzimidazol-5-yl) (4fluorophenyl) methanone Poultry, porcine 50 μg/kg Muscle
50 μg/kg Skin + fat
400 μg/kg Liver
300 μg/kg Kidney
Flubendazole Flubendazole Poultry 400 μg/kg Eggs
Mebendazole Sum of mebendazole methyl (5-(1-hydroxy, 1-phenyl) methyl-1H-benzimidazol-2-yl) carbamate and (2-amino-1H-benzimidazol-5-yl) phenylmethanone, expressed as mebendazole equivalents Ovine, caprine, equidae 60 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
60 μg/kg Fat
400 μg/kg Liver
60 μg/kg Kidney
Netobimin Sum of albendazole oxide, albendazole sulphone and albendazole 2-aminosulphone, expressed as albendazole Bovine, ovine 100 μg/kg Muscle For oral use only
100 μg/kg Fat
1000 μg/kg Liver
500 μg/kg Kidney
100 μg/kg Milk
Oxfendazole Sum of extractable residues which may be oxidised to oxfendazole sulphone All ruminants 50 μg/kg Muscle
50 μg/kg Fat
500 μg/kg Liver
50 μg/kg Kidney
10 μg/kg Milk
Oxibendazole Oxibendazole Porcine 100 μg/kg Muscle
500 μg/kg Skin and fat
200 μg/kg Liver
100 μg/kg Kidney
Thiabendazole Sum of thiabendazole and 5-hydroxythiabendazole Caprine 100 μg/kg Muscle
100 μg/kg Fat
100 μg/kg Liver
100 μg/kg Kidney
100 μg/kg Milk
Triclabendazole Sum of extractable residues that may be oxidised to ketotriclabendazole All ruminants 225 μg/kg Muscle
100 μg/kg Fat
250 μg/kg Liver
150 μg/kg Kidney
 2.1.4.Phenol derivatives including salicylanides
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Nitroxinil Nitroxinil Bovine, ovine 400 μg/kg Muscle
200 μg/kg Fat
20 μg/kg Liver
400 μg/kg Kidney
Oxyclozanide Oxyclozanide All ruminants 20 μg/kg Muscle
20 μg/kg Fat
500 μg/kg Liver
100 μg/kg Kidney
10 μg/kg Milk
 2.1.5.Benzenesulphonamides
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Clorsulon Clorsulon Bovine 35 μg/kg Muscle
100 μg/kg Liver
200 μg/kg Kidney
2.1.6.Piperazine derivatives
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Piperazine Piperazine Porcine 400 μg/kg Muscle
800 μg/kg Skind and fat
2000 μg/kg Liver
1000 μg/kg Kidney
Chicken 2000 μg/kg Eggs
2.1.7.Tetrahydropyrimides
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Morantel Sum of residues which may be hydrolysed to N-methyl-1,3- propanediamine and expressed as morantel equivalents Bovine, ovine 100 μg/kg Muscle
100 μg/kg Fat
800 μg/kg Liver
200 μg/kg Kidney
50 μg/kg Milk
All ruminants 100 μg/kg Muscle
100 μg/kg Fat
800 μg/kg Liver
200 μg/kg Kidney
50 μg/kg Milk
2.2.Agents acting against ectoparasites 2.2.1.Organophosphates
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Coumafos Coumafos Bees 100 μg/kg Honey
Diazinon Diazinon Bovine, ovine, caprine 20 μg/kg Milk
Bovine, porcine, ovine, caprine 20 μg/kg Muscle
700 μg/kg Fat
20 μg/kg Liver
20 μg/kg Kidney
Phoxim Phoxim Ovine 50 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
400 μg/kg Fat
50 μg/kg Kidney
Porcine 20 μg/kg Muscle
700 μg/kg Skin and fat
20 μg/kg Liver
20 μg/kg Kidney
Chicken 25 μg/kg Muscle
550 μg/kg Skin + fat
50 μg/kg Liver
30 μg/kg Kidney
60 μg/kg Eggs
2.2.2.Formamidines
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Amitraz Sum of amitraz and all metabolites containing the 2,4-DMA moiety, expressed as amitraz Bovine 200 μg/kg Fat
200 μg/kg Liver
200 μg/kg Kidney
10 μg/kg Milk
Ovine 400 μg/kg Fat
100 μg/kg Liver
200 μg/kg Kidney
10 μg/kg Milk
Porcine 400 μg/kg Skin and fat
200 μg/kg Liver
200 μg/kg Kidney
Bees (honey) 200 μg/kg Honey
Caprine 200 μg/kg Fat
100 μg/kg Liver
200 μg/kg Kidney
10 μg/kg Milk
2.2.3.Pyrethroids
Further provisions in Commission Directive 98/82/EC are to be observed (OJ L 290, 29.10.1998, p. 25).
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Cyhalothrin Cyhalothrin (sum of isomers) Bovine 500 μg/kg Fat Further provisions in Council Directive 94/29/EC are to be observed
50 μg/kg Kidney
50 μg/kg Milk
Cyfluthrin Cyfluthrin (sum of isomers) Bovine 10 μg/kg Muscle
50 μg/kg Fat
10 μg/kg Liver
10 μg/kg Kidney
20 μg/kg Milk
Deltamethrin Deltamethrin All ruminants 10 μg/kg Muscle
50 μg/kg Fat
10 μg/kg Liver
10 μg/kg Kidney
20 μg/kg Milk
Fin fish 10 μg/kg Muscle and skin in natural proportions
Fenvalerate Fenvalerate (sum of RR, SS, RS and SR isomers) Bovine 25 μg/kg Muscle
250 μg/kg Fat
25 μg/kg Liver
25 μg/kg Kidney
40 μg/kg Milk
Flumethrin Flumethrin (sum of trans-Z isomers) Bovine 10 μg/kg Muscle
150 μg/kg Fat
20 μg/kg Liver
10 μg/kg Kidney
30 μg/kg Milk
Ovine 10 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
150 μg/kg Fat
20 μg/kg Liver
10 μg/kg Kidney
Permethrin Permethrin (sum of isomers) Bovine 50 μg/kg Muscle
500 μg/kg Fat
50 μg/kg Liver
50 μg/kg Kidney
50 μg/kg Milk
Cypermethrin Cypermethrin (sum of isomers) Salmonidae 50 μg/kg Muscle and skin in natural proportions
All ruminants 20 μg/kg Muscle
200 μg/kg Fat
20 μg/kg Liver
20 μg/kg Kidney
20 μg/kg Milk
Alphacypermethrin Cypermethrin (sum of isomers) Bovine, ovine 20 μg/kg Muscle
200 μg/kg Fat
20 μg/kg Liver
20 μg/kg Kidney
20 μg/kg Milk
 2.2.4.Acyl urea derivatives
Not for use in animals from which milk is produced for human consumption.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Diflubenzuron Diflubenzuron Salmonidae 1000 μg/kg Muscle and skin in natural proportions
Fluazuron Fluazuron Bovine 200 μg/kg Muscle
7000 μg/kg Fat
500 μg/kg Liver
500 μg/kg Kidney
Teflubenzuron Teflubenzuron Salmonidae 500 μg/kg Muscle and skin in natural proportions
2.2.5.Pyrimidines derivatives
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Dicyclanil Sum of dicyclanil and 2, 4, 6-triamino-pyrimidine-5-carbonitrile Ovine 200 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
150 μg/kg Fat
400 μg/kg Liver
400 μg/kg Kidney
 2.2.6.Triazine derivatives
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Cyromazine Cyromazine Ovine 300 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
300 μg/kg Fat
300 μg/kg Liver
300 μg/kg Kidney
 2.3.Agents acting against endo- and ectoparasites 2.3.1.Avermectins
Not for use in animals from which milk is produced for human consumption.
Phramacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Abamectin Avermectin B1a Bovine 10 μg/kg Fat
20 μg/kg Liver
Ovine 20 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
50 μg/kg Fat
25 μg/kg Liver
20 μg/kg Kidney
Doramectin Doramectin All mammalian food producing species 40 μg/kg Muscle
150 μg/kg Fat
100 μg/kg Liver
60 μg/kg Kidney
Emamectin Emamectin B1a Fin fish 100 μg/kg Muscle and skin in natural proportions
Eprinomectin Eprinomectin B1a Bovine 50 μg/kg Muscle
250 μg/kg Fat
1500 μg/kg Liver
300 μg/kg Kidney
20 μg/kg Milk
Ivermectin 22, 23-Dihydro-avermectin B1a Bovine 40 μg/kg Fat
100 μg/kg Liver
Porcine, ovine, equidae 20 μg/kg Fat
15 μg/kg Liver
Deer, including reindeer 20 μg/kg Muscle
100 μg/kg Fat
50 μg/kg Liver
20 μg/kg Kidney
All mammalian food-producing species 100 μg/kg Fat
100 μg/kg Liver
30 μg/kg Kidney
Moxidectin Moxidectin Bovine, ovine 50 μg/kg Muscle
500 μg/kg Fat
100 μg/kg Liver
50 μg/kg Kidney
Bovine 40 μg/kg Milk
Equidae 50 μg/kg Muscle
500 μg/kg Fat
100 μg/kg Liver
50 μg/kg Kidney
Ovine 40 μg/kg Milk
2.4.Agents acting against protozoa 2.4.1.Triazinetrione derivative
Not for use in animals from which milk is produced for human consumption. For porcine species this MRL relates to "skin and fat in natural proportions". Not for use in animals from which eggs are produced for human consumption.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Toltrazuril Toltrazuril sulfone Chicken 100 μg/kg Muscle Not for use in animals from which eggs are produced for human consumption
200 μg/kg Skin and fat
600 μg/kg Liver
400 μg/kg Kidney
Turkey 100 μg/kg Muscle
200 μg/kg Skin and fat
600 μg/kg Liver
400 μg/kg Kidney
Porcine 100 μg/kg Muscle
150 μg/kg Skin and fat
500 μg/kg Liver
250 μg/kg Kidney
All mammalian food producing species 100 μg/kg Muscle
150 μg/kg Fat
500 μg/kg Liver
250 μg/kg Kidney
Poultry 100 μg/kg Muscle
200 μg/kg Skin + fat
600 μg/kg Liver
400 μg/kg Kidney
2.4.2.Quinazolone derivatives
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Halofuginone Halofuginone Bovine 10 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
25 μg/kg Fat
30 μg/kg Liver
30 μg/kg Kidney
 2.4.3.Carbanilides
Not for use in ovine from which milk is produced for human consumption.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Imidocarb Imidocarb Bovine 300 μg/kg Muscle
50 μg/kg Fat
2000 μg/kg Liver
1500 μg/kg Kidney
50 μg/kg Milk
Ovine 300 μg/kg Muscle
50 μg/kg Fat
2000 μg/kg Liver
1500 μg/kg Kidney
2.4.4.Ionophores
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Lasalocid Lasalocid A Poultry 20 μg/kg Muscle
100 μg/kg Skin + fat
100 μg/kg Liver
50 μg/kg Kidney
 3.Agents acting on the nervous system 3.1.Agents acting on the central nervous system 3.1.1.Butyrophenone tranquillisers
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Azaperone Sum of azaperone and azaperol Porcine 100 μg/kg Muscle
100 μg/kg Skin and fat
100 μg/kg Liver
100 μg/kg Kidney
3.2.Agents acting on the autonomic nervous system 3.2.1.Anti-adrenergics
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Carazolol Carazolol Porcine 5 μg/kg Muscle
5 μg/kg Skin and fat
25 μg/kg Liver
25 μg/kg Kidney
Bovine 5 μg/kg Muscle
5 μg/kg Fat
15 μg/kg Liver
15 μg/kg Kidney
1 μg/kg Milk
3.2.2.β2 sympathomimetic agents
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Clenbuterol hydrochloride Clenbuterol Bovine 0,1 μg/kg Muscle
0,5 μg/kg Liver
0,5 μg/kg Kidney
0,05 μg/kg Milk
Equidae 0,1 μg/kg Muscle
0,5 μg/kg Liver
0,5 μg/kg Kidney
4.Anti-inflammatory agents 4.1.Nonsteroidal anti-inflammatory agents 4.1.1.Arylpropionic acid derivative
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Carprofen Carprofen BovineNot for use in animals from which milk is produced for human consumption 500 μg/kg Muscle
1000 μg/kg Fat
1000 μg/kg Liver
1000 μg/kg Kidney
Equidae 500 μg/kg Muscle
1000 μg/kg Fat
1000 μg/kg Liver
1000 μg/kg Kidney
Vedaprofen Vedaprofen Equidae 50 μg/kg Muscle
20 μg/kg Fat
100 μg/kg Liver
1000 μg/kg Kidney
Carprofen Sum of carprofen and carprofen glucuronide conjugate Bovine, equidae 500 μg/kg Muscle
1000 μg/kg Fat
1000 μg/kg Liver
1000 μg/kg Kidney
4.1.2.Fenamate group derivatives
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Flunixin Flunixin Bovine 20 μg/kg Muscle
30 μg/kg Fat
300 μg/kg Liver
100 μg/kg Kidney
5-Hydroxyflunixin 40 μg/kg Milk
Flunixin Porcine 50 μg/kg Muscle
10 μg/kg Skin and fat
200 μg/kg Liver
30 μg/kg Kidney
Equidae 10 μg/kg Muscle
20 μg/kg Fat
100 μg/kg Liver
200 μg/kg Kidney
Tolfenamic acid Tolfenamic acid Bovine 50 μg/kg Muscle
400 μg/kg Liver
100 μg/kg Kidney
50 μg/kg Milk
Porcine 50 μg/kg Muscle
400 μg/kg Liver
100 μg/kg Kidney
4.1.3.Enolic acid derivates
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Meloxicam Meloxicam Equidae 20 μg/kg Muscle
65 μg/kg Liver
65 μg/kg Kidney
4.1.4.Oxican derivatives
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Meloxicam Meloxicam Porcine, equidae, rabbit 20 μg/kg Muscle
65 μg/kg Liver
65 μg/kg Kidney
Bovine, caprine 20 μg/kg Muscle
65 μg/kg Liver
65 μg/kg Kidney
15 μg/kg Milk
 4.1.5.Pyrazolone derivatives
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Metamizole 4-Methylaminoantipyrin Bovine 100 μg/kg Muscle
100 μg/kg Fat
100 μg/kg Liver
100 μg/kg Kidney
50 μg/kg Milk
Porcine 100 μg/kg Muscle
100 μg/kg Skin and fat
100 μg/kg Liver
100 μg/kg Kidney
Equidae 100 μg/kg Muscle
100 μg/kg Fat
100 μg/kg Liver
100 μg/kg Kidney
4.1.6.Phenyl acetic acid derivatives
Not for use in animals from which milk is produced for human consumption.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Diclofenac Diclofenac Bovine 5 μg/kg Muscle
1 μg/kg Fat
5 μg/kg Liver
10 μg/kg Kidney
Porcine 5 μg/kg Muscle
1 μg/kg Skin + fat
5 μg/kg Liver
10 μg/kg Kidney
4.1.7.Sulphonated fenyl lactones
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Firocoxib Firocoxib Equidae 10 μg/kg Muscle
15 μg/kg Fat
60 μg/kg Liver
10 μg/kg Kidney
 5.Corticoides 5.1.Glucocorticoides
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Betamethasone Betamethasone Bovine 0,75 μg/kg Muscle
2,0 μg/kg Liver
0,75 μg/kg Kidney
0,3 μg/kg Milk
Porcine 0,75 μg/kg Muscle
2,0 μg/kg Liver
0,75 μg/kg Kidney
Dexamethasone Dexamethasone Bovine 0,3 μg/kg Milk
Bovine, porcine, equidae 0,75 μg/kg Muscle
2 μg/kg Liver
0,75 μg/kg Kidney
Caprine 0,75 μg/kg Muscle
2 μg/kg Liver
0,75 μg/kg Kidney
0,3 μg/kg Milk
Methylprednisolone Methylprednisolone Bovine 10 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
10 μg/kg Fat
10 μg/kg Liver
10 μg/kg Kidney
Prednisolone Prednisolone Bovine 4 μg/kg Muscle
4 μg/kg Fat
10 μg/kg Liver
10 μg/kg Kidney
6 μg/kg Milk
6.Agents acting on the reproductive system 6.1.Progestogens
Only for zootechnical use and in accordance with the provisions of Directive 96/22/EC. For therapeutic and zootechnical purposes only.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Chlormadinone Chlormadinone Bovine 4 μg/kg Fat For zootechnical use only
2 μg/kg Liver
2,5 μg/kg Milk
Flugestone acetate Flugetone acetate Ovine 1 μg/kg Milk For intravaginal use for zootechnical purposes only
Caprine 1 μg/kg Milk For intra-vaginal use for zootechnical purposes only
Ovine, caprine 0,5 μg/kg Muscle For therapeutic and zootechnical purposes only
0,5 μg/kg Fat
0,5 μg/kg Liver
0,5 μg/kg Kidney
Altrenogest Altrenogest Porcine 1 μg/kg Skin and fat
0,4 μg/kg Liver
Equidae 1 μg/kg Fat
0,9 μg/kg Liver
Norgestomet Norgestomet Bovine 0,2 μg/kg Muscle
0,2 μg/kg Fat
0,2 μg/kg Liver
0,2 μg/kg Kidney
0,12 μg/kg Milk
ANNEX II LIST OF SUBSTANCES NOT SUBJECT TO MAXIMUM RESIDUE LIMITS 1.Inorganic chemicals
Pharmacologically active substance(s) Animal species Other provisions
Aluminium distearate All food-producing species
Aluminium hydroxide acetate All food-producing species
Aluminium phosphate All food-producing species
Aluminium salicylate, basic Bovine For oral use only; Not for use in animals from which milk is produced for human consumption
Aluminium tristearate All food-producing species
Ammonium chloride All food-producing species
Barium selenate Bovine, ovine
Bismuth subcarbonate All food-producing species For oral use only
Bismuth subgallate All food-producing species For oral use only
Bismuth subnitrate All food-producing species For oral use only
Bismuth subsalicylate All food-producing species For oral use only
Boric acid and borates All food-producing species
Bromide, potassium salt All food producing species
Bromide, sodium salt All mammalian food-producing species For topical use only
Calcium acetateCalcium benzoateCalcium carbonateCalcium chlorideCalcium gluconateCalcium hydroxideCalcium hypophosphiteCalcium malateCalcium oxideCalcium phosphateCalcium polyphosphatesCalcium propionateCalcium silicateCalcium stearateCalcium sulphate All food-producing species
Calcium glucoheptonate All food-producing species
Calcium glucono glucoheptonate All food-producing species
Calcium gluconolactate All food-producing species
Calcium glutamate All food-producing species
Calcium glycerophosphate All food producing species
Cobalt carbonate All food-producing species
Cobalt dichloride All food-producing species
Cobalt gluconate All food-producing species
Cobalt oxide All food-producing species
Cobalt sulphate All food-producing species
Cobalt trioxide All food-producing species
Copper chloride All food-producing species
Copper gluconate All food-producing species
Copper heptanoate All food-producing species
Copper methionate All food-producing species
Copper oxide All food-producing species
Copper sulphate All food-producing species
Dicopper oxide All food-producing species
Hydrochloric acid All food-producing species For use as excipient
Hydrogen peroxide All food-producing species
Iodine and iodine inorganic compounds including: Sodium and potassium-iodide Sodium and potassium-iodate Iodophors including polyvinylpyrrolidone-iodine All food-producing species
Iron dichloride All food-producing species
Iron sulphate All food-producing species
MagnesiumMagnesium sulphateMagnesium hydroxideMagnesium stearateMagnesium glutamateMagnesium orotateMagnesium aluminium silicateMagnesium oxideMagnesium carbonateMagnesium phosphateMagnesium glycerophosphateMagnesium aspartateMagnesium citrateMagnesium acetateMagnesium trisilicate All food-producing species
Nickel gluconate All food-producing species
Nickel sulphate All food-producing species
Potassium DL-aspartate All food-producing species
Potassium glucuronate All food-producing species
Potassium glycerophosphate All food-producing species
Potassium nitrate All food-producing species
Potassium selenate All food-producing species
Sodium chlorite Bovine For topical use only
Sodium dichloroisocyanurate Bovine, ovine, caprine For topical use only
Sodium glycerophosphate All food producing species
Sodium hypophosphite All food-producing species
Sodium nitrite Bovine For topical use only
Sodium propionate All food producing species
Sodium selenate All food-producing species
Sodium selenite All food-producing species
Sulphur All food producing species
Zinc acetateZinc chlorideZinc gluconateZinc oleateZinc stearate All food-producing species
2.Organic compounds
Only for intravaginal therapeutic or zootechnical use and in accordance with the provisions of Directive 96/22/EC. For oral use only. For oral use; not for use in animals from which milk is produced for human consumption. For inhalation use only. For topical use only.
Pharmacologically active substance(s) Animal species Other provisions
17β-Oestradiol All mammalian food-producing species For therapeutic and zootechnical uses only
2-Aminoethanol All food-producing species
2-Aminoethyl dihydrogenphosphate All food-producing species
2-Pyrrolidone All food-producing species At parenteral doses up to 40 mg/kg bw
8-Hydroxyquinoline All mammalian food-producing species For topical use in newborn animals only
Acetyl cysteine All food-producing species
Alfacalcidol Bovine For parturient cows only
Alfaprostol RabbitsBovine, porcine, equidae
Bacitracin Bovine For intramammary use in lactating cows only and for all tissues except milk
Benzalkonium chloride All food-producing species For use as an excipient at concentrations up to 0,05 % only
Benzocaine All food-producing species For use as local anaesthetic only
Benzylalcohol All food-producing species For use as excipient
Betaine All food-producing species
Bronopol Salmonidae For use only on farmed fertilised eggs
Brotizolam Bovine For therapeutic uses only
Buserelin All food-producing species
Butorphanol tartrate Equidae For intravenous administration only
Butyl 4-hydroxybenzoate All food-producing species
Butylscopolaminium bromide All food-producing species
Caffeine All food-producing species
Carbetocin All mammalian food-producing species
Cefazolin BovineOvine, caprine For intramammary use, except if the udder may be used as food for human consumption
Cetostearyl alcohol All food-producing species
Cetrimide All food-producing species
Chlorhexidine All food-producing species For topical use only
Chlorocresol All food-producing species
Clazuril Pigeon
Cloprostenol Bovine, porcine, equidae
Coco alkyl dimethyl betaines All food-producing species For use as excipient
Corticotropin All food-producing species
D-Phe 6 -luteinising-hormone releasing hormone All food-producing species
Dembrexine Equidae
Denaverine hydrochloride Bovine
Detomidine Bovine, equidae For therapeutic uses only
Diclazuril All ruminantsPorcine
Diethyl phtalate All food-producing species
Diethylene glycol monoethyl ether Bovine, porcine
Dimanganese trioxide All food-producing species For oral use only
Dimethyl phtalate All food-producing species
Dinoprost All mammalian food-producing species
Dinoprost tromethamine All mammalian food-producing species
Diprophylline All food-producing species
Etamiphylline camsylate All food-producing species
Ethanol All food-producing species For use as excipient
Ethyl lactate All food-producing species
Etiproston tromethamine Bovine, porcine
Fertirelin acetate Bovine
Flumethrin Bees (honey)
Folic acid All food-producing species
Glycerol formal All food-producing species
Gonadotrophin releasing hormone All food-producing species
Heptaminol All food-producing species
Hesperidin Equidae
Hesperidin methyl chalcone Equidae
Hexetidine Equidae For topical use only
Human chorion gonadotrophin All food-producing species
Human menopausal urinary gonadotrophin Bovine
Hydrocortisone All food-producing species For topical use only
Iodine organic compounds Iodoform All food-producing species
Isobutane All food-producing species
Isoflurane Equidae For use as anaesthetic only
Isoxsuprine Bovine, equidae For therapeutic use only in accordance with Council Directive 96/22/EEC (OJ L 125, 23.5.1996, p. 3)
Ketamine All food-producing species
Ketanserin tartrate Equidae
Ketoprofen Bovine, porcine, equidae
L-tartaric acid and its mono- and di-basic salt of sodium, potassium and calcium All food-producing species For use as excipient
Lactic acid All food-producing species
Lecirelin Bovine, equidae, rabbits
Lobeline All food-producing species
Luprostiol All mammalian species
Malic acid All food-producing species For use as excipient
Manganese carbonate All food-producing species For oral use only
Manganese chloride All food-producing species For oral use only
Manganese gluconate All food-producing species For oral use only
Manganese glycerophosphate All food-producing species For oral use only
Manganese oxide All food-producing species For oral use only
Manganese pidolate All food-producing species For oral use only
Manganese ribonucleate All food-producing species For oral use only
Manganese sulphate All food-producing species For oral use only
Mecillinam Bovine For intrauterine use only
Medroxyprogesterone acetate Ovine For intravaginal use for zootechnical purposes only
Melatonin Ovine, caprine
Menadione All food-producing species
Menbutone Bovine, ovine, caprine, porcine, equidae
Menthol All food-producing species
Methyl nicotinate Bovine, equidae For topical use only
Mineral hydrocarbons, low to high viscosity including microcristalline waxes, approximately C10-C60; aliphatic, branched aliphatic and alicyclic compounds All food-producing species Excludes aromatic and unsaturated compounds
N-butane All food-producing species
N-butanol All food-producing species For use as excipient
Natamycin Bovine, equidae For topical use only
Neostigmine All food-producing species
Nicoboxil Equidae For topical use only
Nonivamide Equidae For topical use only
Oleyloleate All food-producing species For topical use only
Oxytocin All mammalian food-producing species
Pancreatin All mammalian food-producing species For topical use only
Papain All food-producing species
Papaverine Bovine Newborn calves only
Peracetic acid All food-producing species
Phenol All food-producing species
Phloroglucinol All food-producing species
Phytomenadione All food-producing species
Policresulen All food-producing species For topical use only
Polyethylene glycol 15 hydroxystearate All food-producing species For use as excipient
Polyethylene glycol 7 glyceryl cocoate All food-producing species For topical use only
Polyethylene glycol stearates with 8-40 oxyethylene units All food-producing species For use as excipient
Polysulphated glycosaminoglycan Equidae
Praziquantel OvineEquidae For use in non-lactating sheep only
Pregnant mare serum gonadotrophin All food-producing species
Prethcamide (crotethamide and cropropamide) All mammalian food-producing species
Procaine All food-producing species
Propane All food-producing species
Propylene glycol All food-producing species
Quatresin All food-producing species For use as preservative only at concentrations of up to 0,5 %
R-Cloprostenol Bovine, porcine, equidae
Rifaximin All mammalian food-producing speciesBovine For topical use onlyFor intramammary use, except if the udder may be used as food for human consumption
Romifidine Equidae For therapeutic uses only
Sodium 2-methyl-2-phenoxy-propanoate Bovine, porcine, caprine, equidae
Sodium benzyl 4-hydroxybenzoate All food-producing species
Sodium butyl 4-hydroxybenzoate All food-producing species
Sodium cetostearyl sulphate All food-producing species For topical use only
Somatosalm Salmon
Tanninum All food-producing species
Tau fluvalinate
Terpin hydrate Bovine, porcine, ovine, caprine
Tetracaine All food-producing species For use as anaesthetic only
Theobromine All food-producing species
Theophylline All food-producing species
Thiomersal All food-producing species For use only as preservatives in multidose vaccines at a concentration not exceeding 0,02 %
Thymol All food-producing species
Timerfonate All food-producing species For use only as preservatives in multidose vaccines at a concentration not exceeding 0,02 %
Trimethylphloroglucinol All food-producing species
Vitamin D All food-producing species
Wool alcohols All food-producing species For topical use only
1-Methyl-2-pyrrolidone Equidae
Cefacetrile Bovine For intramammary use only and for all tissues except milk
Enilconazole Bovine, equidae For topical use only
Etamsylate All food producing species
Strychnine Bovine For oral use only at dose to 0,1 mg/kg bw
Parconazole Guinea fowl
Biotin All food producing species
Bromhexine BovineNot for use in animals from which milk is produced for human consumption
Porcine
PoultryNot for use in animals from which eggs are produced for human consumption
Mercaptamine hydrochloride All mammalian food-producing species
Praziquantel Ovine
Pyrantel embonate Equidae
Vitamin B1 All food-producing species
Vitamin B12 All food-producing species
Vitamin B2 All food-producing species
Vitamin B3 All food-producing species
Vitamin B5 All food-producing species
Vitamin B6 All food-producing species
Vitamin E All food-producing species
Tiaprost Bovine, ovine, porcine, equidae
Apramycin Porcine, rabbitsOvineNot for use in animals from which milk is produced for human consumptionChickenNot for use in animals from which eggs are produced for human consumption For oral use only
Azamethiphos Salmonidae
Doxapram All mammalian food producing species
Piperonyl butoxide Bovine, ovine, caprine, equidae For topical use only
Sulfogaiacol All food producing species
Vetrabutine hydrochloride Porcine
Fenpipramide hydrochloride Equidae For intravenous use only
Hydrochlorothiazide Bovine
Levomethadone Equidae For intravenous use only
Tricaine mesilate Fin fish For water borne use only
Trichlormethiazide All mammalian food producing species Not for use in animals from which milk is produced for human consumption
Vincamine Bovine For use in newborn animals only
Atropine All food producing species
Cefoperazone Bovine For intramammary use in lactating cows only and for all tissues except milk
2-aminoethanol glucuronate All food-producing species
Betaine glucuronate All food-producing species
Bituminosulfonates, ammonium and sodium salts All mammalian food producing species For topical use only
Chlorphenamine All mammalian food-producing species
Humic acids and their sodium salts All food-producing species For oral use only
Paracetamol Porcine For oral use only
Tosylchloramide sodium Fin fish For water-borne use only
Bovine For topical use only
Equidae For topical use only
1-methyl-2-pyrrolidone All food-producing species
Ergometrine maleate All mammalian food-producing species For use in parturient animals only
Jecoris oleum All food-producing species For topical use only
Mepivacaine Equidae For intra-articular and epidural use as local anaesthetic only
Novobiocin Bovine For intrammary use only and for all tissues except milk
Piperazine dihydrochloride Chicken For all tissues except eggs
Polyoxyl castor oil with 30 to 40 oxyethylene units All food-producing species For use as excipient
Polyoxyl hydrogenated castor oil with 40 to 60 oxyethylene units All food-producing species For use as excipient
Xylazine hydrochloride Bovine, equidae Not for use in animals from which milk is produced for human consumptiom
Butafosfan Bovine For intravenous use only
Cefalonium Bovine For intramammary use and eye treatment only, and for all tissues except milk
Furosemide Bovine, equidae For intravenous administration only
Lidocaine Equidae For local-regional anaesthesia only
3,5-Diiodo-L-thyrosine All mammalian food-producing species
Levothyroxine All mammalian food-producing species
Aluminium salicylate, basic All food producing species except fish For topical use only
Bismuth subnitrate Bovine For intramammary use only
Calcium aspartate All food producing species
Methyl salicylate All food producing species except fish For topical use only
Salicylic acid All food producing species except fish For topical use only
Sodium salicylate Bovine, porcine
Zinc aspartate All food producing species
Toldimfos All food producing species
Decoquinate Bovine, ovine For oral use only. Not for use in animals from which milk is produced for human consumption
Sodium boroformiate All food producing species
Thiamylal All mammalian food producing species For intravenous administration only
Thiopental sodium All food-producing species For intravenous administration only
Acetylsalicylic acid All food producing species except fish Not for use in animals from which milk or eggs are produced for human consumption
Acetylsalicylic acid DL-lysine All food producing species except fish Not for use in animals from which milk or eggs are produced for human consumption
Carbasalate calcium All food producing species except fish Not for use in animals from which milk or eggs are produced for human consumption
Sodium acetylsalicylate All food producing species except fish Not for use in animals from which milk or eggs are produced for human consumption
Linear alkyl benzene sulphonic acids with alkyl chain lengths ranging from C9 to C13, containing less than 2,5 % of chains longer than C13 Bovine For topical use only
Ovine
Amprolium Poultry For oral use only
Tiludronic acid, disodium salt Equidae For intravenous use only
Sorbitan trioleate All food-producing species
Vitamin A All food producing species
Ammonium lauryl sulphate All food-producing species
Bronopol Fin fish
Calcium pantothenate All food-producing species
Allantoin All food producing species For topical use only
Benzocaine Salmonidae
Dexpanthenol All food producing species
Azagly-nafarelin Salmonidae Not for use in fish from which eggs are produced for human consumption
Deslorelin acetate Equidae
Hydroxyethylsalicylate All food producing species except fish For topical use only
Xylazine hydrochloride Bovine, equidae
Omeprazole Equidae For oral use only
Trichlormethiazide All mammalian food producing species
Progesterone Bovine, ovine, caprine, Equidae (female)
Beclomethasone dipropionate Equidae
Cloprostenol Caprine
R-cloprostenol Caprine
Sorbitan sesquioleate All food producing species
Diethylene glycol monoethyl ether All ruminants and porcine
Peforelin Porcine
Dinoprostone All mammalian species
3.Substances generally recognised as safe
Pharmacologically active substance(s) Animal species Other provisions
Absinthium extract All food-producing species
Acetylmethionine All food-producing species
Aluminium hydroxide All food-producing species
Aluminium monostearate All food-producing species
Ammonium sulfate All food-producing species
Benzyl benzoate All food-producing species
Benzyl p-hydroxybenzoate All food-producing species
Calcium borogluconate All food-producing species
Calcium citrate All food-producing species
Camphor All food-producing species External use only
Cardamon extract All food-producing species
Diethyl sebacate All food-producing species
Dimethicone All food-producing species
Dimethyl acetamide All food-producing species
Dimethyl sulphoxide All food-producing species
Epinephrine All food-producing species
Ethyl oleate All food-producing species
Ethylenediaminetetraacetic acid and salts All food-producing species
Eucalyptol All food-producing species
Follicle stimulating hormone (natural FSH from all species and their synthetic analogues) All food-producing species
Formaldehyde All food-producing species
Formic acid All food-producing species
Glutaraldehyde All food-producing species
Guaiacol All food-producing species
Heparin and its salts All food-producing species
Human chorionic gonadotropin (natural HCG and its synthetic analogues) All food-producing species
Iron ammonium citrate All food-producing species
Iron dextran All food-producing species
Iron glucoheptonate All food-producing species
Isopropanol All food-producing species
Lanolin All food-producing species
Luteinising hormone (natural LH from all species and their synthetic analogues) All food-producing species
Magnesium chloride All food-producing species
Magnesium gluconate All food-producing species
Magnesium hypophosphite All food-producing species
Mannitol All food-producing species
Methylbenzoate All food-producing species
Monothioglycerol All food-producing species
Montanide All food-producing species
Myglyol All food-producing species
Orgotein All food-producing species
Poloxalene All food-producing species
Poloxamer All food-producing species
Polyethylene glycols (molecular weight ranging from 200 to 10000) All food-producing species
Polysorbate 80 All food-producing species
Serotonin All food-producing species
Sodium chloride All food-producing species
Sodium cromoglycate All food-producing species
Sodium dioctylsulphosuccinate All food-producing species
Sodium formaldehydesulphoxylate All food-producing species
Sodium lauryl sulphate All food-producing species
Sodium pyrosulphite All food-producing species
Sodium stearate All food-producing species
Sodium thiosulphate All food-producing species
Tragacanth All food-producing species
Urea All food-producing species
Zinc oxide All food-producing species
Zinc sulphate All food-producing species
Adenosine and its 5′-mono-, 5′-di- and 5′-triphosphates All food producing species
Alanine All food producing species
Arginine All food producing species
Asparagine All food producing species
Aspartic acid All food producing species
Carnitine All food producing species
Choline All food producing species
Chymotrypsin All food producing species
Citrulline All food producing species
Cysteine All food producing species
Cytidine and its 5′-mono-, 5′-di- and 5′-triphosphates All food producing species
Glutamic acid All food producing species
Glutamine All food producing species
Glycine All food producing species
Guanosine and its 5′-mono-, 5′-di- and 5′-triphosphates All food producing species
Histidine All food producing species
Hyaluronic acid All food producing species
Inosine and its 5′-mono-, 5′-di- and 5′-triphosphates All food producing species
Inositol All food producing species
Isoleucine All food producing species
Leucine All food producing species
Lysine All food producing species
Methionine All food producing species
Ornithine All food producing species
Orotic acid All food producing species
Pepsin All food producing species
Phenylalanine All food producing species
Proline All food producing species
Serine All food producing species
Thioctic acid All food producing species
Threonine All food producing species
Thymidine All food producing species
Trypsin All food producing species
Tryptophan All food producing species
Tyrosine All food producing species
Uridine and its 5′-mono-, 5′-di- and 5′-triphosphates All food producing species
Valine All food producing species
Polyoxyethylene sorbitan monooleate All food producing species
Polyoxyethylene sorbitan monooleate and trioleate All food-producing species
4.Substances used in homeopathic veterinary medicinal products
Pharmacologically active substance(s) Animal species Other provisions
All substances used in homeopathic veterinary medicinal products provided that their concentration in the product does not exceed one part per ten thousand All food-producing species
Adonis vernalis All food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per hundred only
Acqua levici All food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias only
Atropa belladonna All food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per hundred only
Convallaria majalis All food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per thousand only
Apocynum cannabinum All food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per hundred onlyFor oral use only
Harunga madagascariensis All food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per hundred only
Selenicereus grandiflorus All food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per hundred only
Thuja occidentalis All food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per hundred only
Virola sebifera All food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per thousand only
Ruta graveolens All food-producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per thousand only.Not for use in animals from which milk is produced for human consumption
Aesculus hippocastanum All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations in the products not exceeding one part per ten only
Agnus castus All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Ailanthus altissima All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Allium cepa All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Arnicae radix All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding in the products not exceeding one part per ten only
Artemisia abrotanum All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Bellis perennis All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Calendula officinalis All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding in the products not exceeding one part per ten only
Camphora All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations in the products not exceeding one part per hundred only.
Cardiospermum halicacabum All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Crataegus All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Echinacea All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof onlyFor topical use only.For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding in the products not exceeding one part per ten only
Eucalyptus globulus All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Euphrasia officinalis All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Ginkgo biloba All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations in the products not exceeding one part per thousand only.
Ginseng All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Hamamelis virginiana All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations in the products not exceeding one part per ten only
Harpagophytum procumbens All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Hypericum perforatum All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Lachnanthes tinctoria All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations in the products not exceeding one part per thousand only.
Lobaria pulmonaria All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Okoubaka aubrevillei All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Prunus laurocerasus All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations in the products not exceeding one part per thousand only.
Serenoa repens All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Silybum marianum All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Solidago virgaurea All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Syzygium cumini All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Turnera diffusa All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Viscum album All-food producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias at concentrations corresponding to the mother tincture and dilutions thereof only
Phytolacca americana All food-producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per thousand only
Urginea maritima All food-producing species For use in homeopathic veterinary medicinal products prepared according to homeopathic pharmacopoeias, at concentrations in the products not exceeding one part per hundred onlyFor oral use only
 5.Substances used as food additives in foodstuffs for human consumption
Pharmacologically active substance(s) Animal species Other provisions
Substances with an E number All food-producing species Only substances approved as additives in foodstuffs for human consumption, with the exception of preservatives listed in part C of Annex III to European Parliament and Council Directive 95/2/EC (OJ L 61, 18.3.1995, p. 1).
 6.Substances of vegetable origin
Pharmacologically active substance(s) Animal species Other provisions
Aloe vera gel and whole leaf extract of Aloe vera All food-producing species For topical use only
Aloes, Barbados and Capae, their standardised dry extract and preparations thereof All food-producing species
Angelicae radix aetheroleum All food-producing species
Anisi aetheroleum All food-producing species
Anisi stellati fructus, standardised extracts and preparations thereof All food producing species
Arnica montana (arnicae flos and arnicae planta tota) All food-producing species For topical use only
Balsamum peruvianum All food-producing species For topical use only
Boldo folium All food-producing species
Calendulae flos All food-producing species For topical use only
Capsici fructus acer All food-producing species
Carlinae radix All food-producing species For topical use only
Carvi aetheroleum All food-producing species
Caryophylli aetheroleum All food-producing species
Centellae asiaticaer extractum All food producing species For topical use only
Chrysanthemi cinerariifolii flos All food-producing species For topical use only
Cimicifugae racemosae rhizoma All food-producing species Not for use in animals from which milk is produced for human consumptiom
Cinchonae cortex, standardised extracts and preparations thereof All food producing species
Cinnamomi cassiae aetheroleum All food-producing species
Cinnamomi cassiae cortex, standardised extracts and preparations thereof All food producing species
Cinnamomi ceylanici aetheroleum All food-producing species
Cinnamomi ceylanici cortex, standardised extracts and preparations thereof All food producing species
Citri aetheroleum All food-producing species
Citronellae aetheroleum All food-producing species
Condurango cortex, standardised extracts and preparations thereof All food producing species
Coriandri aetheroleum All food-producing species
Cupressi aetheroleum All food-producing species For topical use only
Echinacea purpurea All food-producing species For topical use only
Eucalypti aetheroleum All food-producing species
Foeniculi aetheroleum All food-producing species
Frangulae cortex, standardised extracts and preparations thereof All food producing species
Gentianae radix, standardised extracts and preparations thereof All food producing species
Ginseng, standardised extracts and preparations thereof All food-producing species
Hamamelis virginiana All food-producing species For topical use only
Hippocastani semen All food-producing species For topical use only
Hyperici oleum All food-producing species For topical use only
Juniperi fructus All food-producing species
Lauri folii aetheroleum All food-producing species
Lauri fructus All food-producing species
Lavandulae aetheroleum All food-producing species For topical use only
Lespedeza capitata All food-producing species
Lini oleum All food-producing species
Majoranae herba All food-producing species
Matricaria recutita and preparations thereof All food producing species
Matricariae flos All food-producing species
Medicago sativa extractum All food-producing species For topical use only
Melissae aetheroleum All food producing species
Melissae folium All food-producing species
Menthae arvensis aetheroleum All food-producing species
Menthae piperitae aetheroleum All food-producing species
Millefolii herba All food-producing species
Myristicae aetheroleum All food-producing species For use in newborn animals only
Piceae turiones recentes extractum All food producing species For oral use only
Oxidation products of Terebinthinae oleum Bovine, porcine, ovine, caprine
Pyrethrum extract All food-producing species For topical use only
Quercus cortex All food-producing species
Quillaia saponins All food-producing species
Rhei radix, standardised extracts and preparations thereof All food producing species
Ricini oleum All food-producing species For use as excipient
Rosmarini aetheroleum All food-producing species
Rosmarini folium All food-producing species
Ruscus aculeatus All food-producing species For topical use only
Salviae folium All food-producing species
Sambuci flos All food-producing species
Sinapis nigrae semen All food-producing species
Strychni semen Bovine, ovine, caprine For oral use only at doses up to the equivalent of 0,1 mg strychnine/kg bw
Symphyti radix All food-producing species For topical use on intact skin only
Terebinthinae aetheroleum rectificatum All food-producing species For topical use only
Terebinthinae laricina All food-producing species For topical use only
Thymi aetheroleum All food-producing species
Tiliae flos All food-producing species
Urticae herba All food-producing species
7.Anti-infectious agents
Pharmacologically active substance(s) Animal species Other provisions
Oxalic acid Honey bees
8.Anti-inflammatory agents
For bovine milk only.
Pharmacologically active substance(s) Animal species Other provisions
Carprofen Bovine
ANNEX III LIST OF PHARMACOLOGICALLY ACTIVE SUBSTANCES USED IN VETERINARY MEDICINAL PRODUCTS FOR WHICH PROVISIONAL MAXIMUM RESIDUE LIMITS HAVE BEEN FIXED 1.Anti-infectious agents 1.1.Chemotheurapeutics 1.1.2.Benzenesulphonamides
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Clorsulon Clorsulon Bovine 50 μg/kg Muscle Provisional MRLs expire on 1 January 2000
150 μg/kg Liver
400 μg/kg Kidney
1.2.Antibiotics 1.2.1.Beta-lactamase inhibitors
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Clavulanic acid Clavulanic acid Bovine, ovine 200 μg/kg Milk Provisional MRLs expire on 1 July 2001
Bovine, ovine, porcine 200 μg/kg Muscle
200 μg/kg Fat
200 μg/kg Liver
200 μg/kg Kidney
1.2.2.Macrolides
Provisional MRLs expire on 1 July 2006. Not for use in animals from which eggs are produced for human consumption.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Acetylisovaleryltylosin Sum of acetylisovaleryltylosin and 3-O-acetyltylosin Porcine 100 μg/kg Muscle Provisional MRLs expire on 1.7.2001
100 μg/kg Skin and fat
100 μg/kg Liver
100 μg/kg Kidney
Acetylisovaleryltylosin Sum of acetyl-isovaleryltylosin and 3-O-acetyltylosin Poultry 50 μg/kg Skin and fat
50 μg/kg Liver
Erythromycin MRLs apply to all microbiological active residues expressed as erythromycin equivalent Bovine, ovine 40 μg/kg Milk Provisional MRLs expire on 1 June 2000
Bovine, ovine, porcine, poultry 400 μg/kg Muscle
400 μg/kg Fat
400 μg/kg Liver
400 μg/kg Kidney
Poultry 200 μg/kg Eggs
Josamycin Josamycin Chicken 200 μg/kg Muscle Provisional MRLs expire on 1.7.2002
200 μg/kg Fat
200 μg/kg Liver
400 μg/kg Kidney
200 μg/kg Eggs
Sum of the microbiologically active metabolites, expressed as josamycin Porcine 200 μg/kg Muscle Provisional MRLs expire on 1.7.2002
200 μg/kg Skin and fat
200 μg/kg Liver
400 μg/kg Kidney
Tilmicosin Tilmicosin Bovine 40 μg/kg Milk Provisional MRLs expire on 1.1.2001
Tulathromycin (2R,3S,4R,5R,8R,10R,11R,12S, 13S,14R)-2- ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-1-oxa- 6-azacyclopent-decan-15-one expressed as tulathromycin equivalents Bovine 100 μg/kg Fat Provisional MRLs expire on 1 July 2004; not for use in animals from which milk is produced for human consumption
3000 μg/kg Liver
3000 μg/kg Kidney
Porcine 100 μg/kg Skin and fat Provisional MRLs expire on 1 July 2004
3000 μg/kg Liver
3000 μg/kg Kidney
Gamithromycin Gamithromycin Bovine 20 μg/kg Fat Provisional MRLs will expire on 1 July 2009.Not for use in animals producing milk for human consumption
200 μg/kg Liver
100 μg/kg Kidney
 1.2.4.Cephalosporins
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Cefacetrile Cefacetrile Bovine 125 μg/kg Milk Provisional MRLs expire on 1.1.2002For intrammamary use only
Cefalonium Cefalonium Bovine 10 μg/kg Milk Provisional MRLs expire on 1.1.2003
Cefoperazone Cefoperazone Bovine 50 μg/kg Milk Provisional MRLs expire on 1 January 2001
Cefquinome Cefquinome Porcine 50 μg/kg Muscle Provisional MRLs expire on 1.1.2000
50 μg/kg Skin + fat
100 μg/kg Liver
200 μg/kg Kidney
Cephapirin Sum of cephapirin and desacetylcephapirin Bovine 50 μg/kg Muscle Provisional MRLs expire on 1.1.2001
50 μg/kg Fat
50 μg/kg Liver
100 μg/kg Kidney
10 μg/kg Milk
 1.2.5.Aminoglycosides
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Aminosidine Aminosidine Bovine, porcine, rabbits, chicken 500 μg/kg Muscle Provisional MRLs expire on 1 July 2000
1500 μg/kg Liver
1500 μg/kg Kidney
Apramycin Apramycin Bovine 1000 μg/kg Muscle Provisional MRLs expire on 1 July 1999
For use in non-lactating cattle only 1000 μg/kg Fat
10000 μg/kg Liver
20000 μg/kg Kidney
Porcine 1000 μg/kg Muscle
1000 μg/kg Skin and fat
1000 μg/kg Liver
5000 μg/kg Kidney
Dihydrostreptomycin Dihydrostreptomycin Bovine, ovine 500 μg/kg Muscle Provisional MRLs expire on 1.6.2002
500 μg/kg Fat
500 μg/kg Liver
1000 μg/kg Kidney
200 μg/kg Milk
Porcine 500 μg/kg Muscle
500 μg/kg Skin and fat
500 μg/kg Liver
1000 μg/kg Kidney
Gentamicin Gentamicin Bovine 100 μg/kg Milk Provisional MRLs expire on 1.6.2002
Bovine, porcine 50 μg/kg Muscle
50 μg/kg Fat
200 μg/kg Liver
750 μg/kg Kidney
Kanamycin Kanamycin Rabbits 100 μg/kg Muscle Provisional MRLs expire on 1.1.2004
100 μg/kg Fat
600 μg/kg Liver
2500 μg/kg Kidney
Bovine, ovine 100 μg/kg Muscle
100 μg/kg Fat
600 μg/kg Liver
2500 μg/kg Kidney
150 μg/kg Milk
Porcine, chicken 100 μg/kg Muscle
100 μg/kg Skin + fat
600 μg/kg Liver
2500 μg/kg Kidney
Neomycin (including framycetin) Neomycin B Bovine, porcine, chicken 500 μg/kg Muscle Provisional MRLs expire on 1.6.2002
500 μg/kg Fat
500 μg/kg Liver
5000 μg/kg Kidney
Bovine 500 μg/kg Milk
Chicken 500 μg/kg Eggs
Spectinomycin Spectinomycin Bovine 200 μg/kg Milk Provisional MRLs expire on 1 July 2000
Bovine, porcine, poultry 300 μg/kg Muscle
500 μg/kg Fat
2000 μg/kg Liver
5000 μg/kg Kidney
OvineNot for use in animals from which milk is produced for human consumption 300 μg/kg Muscle Provisional MRLs expire on 1.1.2002
500 μg/kg Fat
2000 μg/kg Liver
5000 μg/kg Kidney
Chicken 200 μg/kg Eggs
Streptomycin Streptomycin Bovine, ovine 500 μg/kg Muscle Provisional MRLs expire on 1.6.2002
500 μg/kg Fat
500 μg/kg Liver
1000 μg/kg Kidney
200 μg/kg Milk
Porcine 500 μg/kg Muscle
500 μg/kg Skin and fat
500 μg/kg Liver
1000 μg/kg Kidney
1.2.6.Quinolones
Provisional MRLs expire 1 January 2006. Not for use in animals from which milk is produced for human consumption.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Danofloxacin Danofloxacin Porcine 100 μg/kg Muscle Provisional MRLs expire on 1.1.2000
50 μg/kg Skin and fat
200 μg/kg Liver
200 μg/kg Kidney
Decoquinate Decoquinate Bovine, ovine 500 μg/kg Muscle Provisional MRLs expire on 1 July 2000
500 μg/kg Fat
500 μg/kg Liver
500 μg/kg Kidney
Difloxacin Difloxacin BovineNot for use in animals from which milk is produced for human consumption 400 μg/kg Muscle Provisional MRLs expire on 1.1.2001
100 μg/kg Fat
1400 μg/kg Liver
800 μg/kg Kidney
Porcine 400 μg/kg Muscle
100 μg/kg Skin and fat
800 μg/kg Liver
800 μg/kg Kidney
Enrofloxacin Sum of enrofloxacin and ciprofloxacin Ovine 100 μg/kg Muscle Provisional MRLs expire on 1 July 1999
100 μg/kg Fat
300 μg/kg Liver
200 μg/kg Kidney
Flumequine Flumequine Bovine, ovine, porcine, chicken 50 μg/kg Muscle Provisional MRLs expire on 1 January 2000
50 μg/kg Fat or skin and fat
100 μg/kg Liver
300 μg/kg Kidney
Salmonidae 150 μg/kg Muscle and skin
Marbofloxacin Marbofloxacin Bovine 150 μg/kg Muscle Provisional MRLs expire on 1 July 2000
50 μg/kg Fat
150 μg/kg Liver
150 μg/kg Kidney
75 μg/kg Milk
Porcine 150 μg/kg Muscle
50 μg/kg Skin and fat
150 μg/kg Liver
150 μg/kg Kidney
Oxolinic acid Oxolinic acid Bovine 100 μg/kg Muscle
50 μg/kg Fat
150 μg/kg Liver
150 μg/kg Kidney
Porcine 100 μg/kg Muscle
50 μg/kg Skin + fat
150 μg/kg Liver
150 μg/kg Kidney
Chicken 100 μg/kg Muscle
50 μg/kg Skin + fat
150 μg/kg Liver
150 μg/kg Kidney
50 μg/kg Eggs
Fin fish 300 μg/kg Muscle and skin in natural proportions
1.2.9.Polymyxins
Phamarcologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Colistin Colistin Bovine, ovine 50 μg/kg Milk Provisional MRLs expire on 1.7.2002
Bovine, ovine, porcine, chicken, rabbits 150 μg/kg Muscle
150 μg/kg Fat
150 μg/kg Liver
200 μg/kg Kidney
Chicken 300 μg/kg Eggs
1.2.10.Penicillins
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Nafcillin Nafcillin Bovine 300 μg/kg Muscle Provisional MRLs expire on 1.1.2001
300 μg/kg Fat
300 μg/kg Liver
300 μg/kg Kidney
30 μg/kg Milk
Penethamate Benzylpenicillin Ovine 50 μg/kg Muscle Provisional MRLs expire on 1 January 2000
50 μg/kg Fat
50 μg/kg Liver
50 μg/kg Kidney
4 μg/kg Milk
Porcine 50 μg/kg Muscle
50 μg/kg Fat
50 μg/kg Liver
50 μg/kg Kidney
1.2.11.Florfenicol and related compounds
Provisional MRLs expire on 1 January 2007.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Florfenicol Sum of florfenicol and its metabolites measured as florfenicol-amine Fish 1000 μg/kg Muscle and skin in natural proportions Provisional MRLs expire on 1 July 2001
Thiamphenicol Thiamphenicol Ovine 50 μg/kg Muscle Provisional MRLs expire on 1.1.2001
50 μg/kg Fat
50 μg/kg Liver
50 μg/kg Kidney
Porcine 50 μg/kg Muscle
50 μg/kg Skin + fat
50 μg/kg Liver
50 μg/kg Kidney
Fin fish 50 μg/kg Muscle and skin in natural proportions
Thiamphenicol Thiamphenicol Porcine 50 μg/kg Muscle
50 μg/kg Skin + fat
50 μg/kg Liver
50 μg/kg Kidney
1.2.12.Polypeptides
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Bacitracin Bacitracin Bovine 150 μg/kg Milk Provisional MRLs expire on1.7.2001
 1.2.13.Lincosamides
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Lincomycin Lincomycin Ovine 100 μg/kg Muscle Provisional MRLs expire on 1.1.2001
50 μg/kg Fat
500 μg/kg Liver
1500 μg/kg Kidney
150 μg/kg Milk
Porcine 100 μg/kg Muscle
50 μg/kg Skin + fat
500 μg/kg Liver
1500 μg/kg Kidney
Chicken 100 μg/kg Muscle
50 μg/kg Skin + fat
500 μg/kg Liver
1500 μg/kg Kidney
50 μg/kg Eggs
Pirlimycin Pirlimycin Bovine 100 μg/kg Muscle Provisional MRLs expire on 1.7.2000
100 μg/kg Fat
1000 μg/kg Liver
400 μg/kg Kidney
100 μg/kg Milk
 1.2.14.Pleuromutilines
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Tiamulin Sum of metabolites that may be hydrolysed to 8-a-hydroxymutilin Turkey 100 μg/kg Muscle Provisional MRLs expire on 1.7.2001
100 μg/kg Skin and fat
300 μg/kg Liver
 2.Antiparasitic agents 2.1.Agents acting against endoparasites 2.1.1.Phenol derivatives including salicylanides
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Oxyclozanide Oxyclozanide Bovine 20 μg/kg Muscle Provisional MRLs expire on 1.7.2002
20 μg/kg Fat
500 μg/kg Liver
100 μg/kg Kidney
10 μg/kg Milk
Ovine 20 μg/kg Muscle
20 μg/kg Fat
500 μg/kg Liver
100 μg/kg Kidney
 2.1.2.Benzimidazoles and pro-benzimidazoles
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Albendazole sulphoxide Sum of albendazole, albendazole sulphoxide, albendazole sulphone, and albendazole 2-amino sulphone, expressed as albendazole Bovine, ovine 100 μg/kg Milk Provisional MRLs expire on 1 January 2000
Bovine, ovine, pheasant 100 μg/kg Muscle
100 μg/kg Fat
1000 μg/kg Liver
500 μg/kg Kidney
Mebendazole Sum of mebendazole methyl (5-(1-hidroxy, 1-phenyl) methyl-1H-benzimidazol-2-yl) carbamate and (2-amino-1H-benzimidazol-5-yl) phenylmethanone, expressed as mebendazole equivalents Ovine, caprine, equidaeNot for use in animals from which milk is produced for human consumption 60 μg/kg Muscle Provisional MRLs expire on 1.1.2002
60 μg/kg Fat
400 μg/kg Liver
60 μg/kg Kidney
Netobimin Sum of netobimin and albendazole and metabolites of albendazole measured as 2-amino- benzimidazole sulphone Bovine, ovine, caprine 100 μg/kg Muscle Provisional MRLs expire on 31 July 1999
100 μg/kg Fat
1000 μg/kg Liver
500 μg/kg Kidney
100 μg/kg Milk
2.1.3.Tetrahydropyrimides
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Morantel Sum of residues which may be hydrolysed to N-Methyl-1,3-propanediamine and expressed as morantel equivalents Bovine, ovine 100 μg/kg Muscle Provisional MRLs expire on 1.7.2003
100 μg/kg Fat
800 μg/kg Liver
200 μg/kg Kidney
100 μg/kg Milk
Porcine 100 μg/kg Muscle
100 μg/kg Skin and fat
800 μg/kg Liver
200 μg/kg Kidney
 2.1.5.Piperazine derivatives
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Piperazine Piperazine Porcine 400 μg/kg Muscle Provisional MRLs expire on 1.7.2003
800 μg/kg Skin and fat
2000 μg/kg Liver
1000 μg/kg Kidney
Chicken 2000 μg/kg Eggs
 2.1.6.Salicylanilides
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Rafoxanide Rafoxanide BovineNot for use in animals from which milk is produced for human consumption 30 μg/kg Muscle Provisional MRLs expire on 1.7.2001
30 μg/kg Fat
10 μg/kg Liver
40 μg/kg Kidney
OvineNot for use in animals from which milk is produced for human consumption 100 μg/kg Muscle
250 μg/kg Fat
150 μg/kg Liver
150 μg/kg Kidney
 2.2.Agents acting against ectoparasites 2.2.1.Formamidines
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Amitraz Sum of amitraz and all metabolites containing the 2,4-DMA moeity, expressed as amitraz Bees 200 μg/kg Honey Provisional MRLs expire on 1 July 1999
2.2.2.Iminophenyl thiazolidine derivative
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Cymiazole Cymiazole Bees 1000 μg/kg Honey Provisional MRLs expire on 1.7.2001
2.2.3.Pyretrin and pyrethroids
Provisional MRLs expire on 1 July 2006.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Cyfluthrin Cyfluthrin Bovine 10 μg/kg Muscle Provisional MRLs expire on 1 January 2001
50 μg/kg Fat
10 μg/kg Liver
10 μg/kg Kidney
20 μg/kg Milk
Further provisions in Council Directive 94/29/EC are to be observed (OJ L 189, 23.7.1994, p. 67)
Alphacypermethrin Cypermethrin (sum of isomers) Bovine, ovine 20 μg/kg Muscle Provisional MRLs expire on 1.7.2003Further provisions in Directive 93/57/EC are to be observed
200 μg/kg Fat
20 μg/kg Liver
20 μg/kg Kidney
20 μg/kg MilkFurther provisions in Council Directive 93/57/EC (OJ L 211, 23.8.1992, p. 1) are to be observed
Chicken 50 μg/kg Muscle
50 μg/kg Skin + fat
50 μg/kg Liver
50 μg/kg Kidney
50 μg/kg Eggs
Cypermethrin Cypermethrin (sum of isomers) Bovine 20 μg/kg Muscle Provisional MRLs expire on 1.7.2003Further provisions in Directive 93/57/EC are to be observed
200 μg/kg Fat
20 μg/kg Liver
20 μg/kg Kidney
20 μg/kg Milk
Cypermethrin (sum of isomers) Ovine 20 μg/kg Muscle Provisional MRLs expire on 1.7.2003Not for use in animals from which milk is produced for human consumption
200 μg/kg Fat
20 μg/kg Liver
20 μg/kg Kidney
Porcine 20 μg/kg Muscle
200 μg/kg Skin + fat
20 μg/kg Liver
20 μg/kg Kidney
Chicken 50 μg/kg Muscle
50 μg/kg Skin + fat
50 μg/kg Liver
50 μg/kg Kidney
50 μg/kg Eggs
Salmonidae 50 μg/kg Muscle and skin in natural proportions Provisional MRLs expire on 1.7.2003
Deltamethrin Deltamethrin Bovine 10 μg/kg Muscle Provisional MRLs expire on 1 July 2001
50 μg/kg Fat
10 μg/kg Liver
10 μg/kg Kidney
20 μg/kg Milk
OvineNot for use in animals from which milk is produced for human consumption 10 μg/kg Muscle
50 μg/kg Fat
10 μg/kg Liver
10 μg/kg Kidney
Chicken 10 μg/kg Muscle Provisional MRLs expire on 1.7.2003
50 μg/kg Skin + fat
10 μg/kg Liver
10 μg/kg Kidney
50 μg/kg Eggs
Fin fish 10 μg/kg Muscle and skin in natural proportions Provisional MRLs expire on 1.1.2002
Fenvalerate Fenvalerate (sum of RR, SS, RS and SR isomers) Bovine 25 μg/kg Muscle
250 μg/kg Fat
25 μg/kg Liver
25 μg/kg Kidney
40 μg/kg Milk
Permethrin Permethrin (sum of isomers) Chicken, porcine 50 μg/kg Muscle Provisional MRLs expire on 1.1.2003
500 μg/kg Skin and fat
50 μg/kg Liver
50 μg/kg Kidney
Bovine, caprine 50 μg/kg Muscle Provisional MRLs expire on 1.1.2003
500 μg/kg Fat
50 μg/kg Liver
50 μg/kg Kidney
50 μg/kg Milk Further provisions in Commission Directive 98/82/EC are to be observed (OJ L 290, 29.10.1998, p. 25)
Chicken 50 μg/kg Eggs Provisional MRLs expire on 1.1.2003
2.2.4.Organophosphates
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Azamethiphos Azamethiphos Salmonidae 100 μg/kg Muscle and skin in natural proportions Provisional MRLs expire on 1 June 1999
Coumafos Coumafos Bees 100 μg/kg Honey Provisional MRLs expire on 1.7.2001
Phoxim Phoxim Porcine 20 μg/kg Muscle Provisional MRLs expire on 1 January 2001
700 μg/kg Skin and fat
20 μg/kg Liver
20 μg/kg Kidney
Ovine 50 μg/kg Muscle Provisional MRLs expire on 1.7.2001; not for use in animals from which milk is produced for human consumption
400 μg/kg Fat
50 μg/kg Kidney
Chicken 50 μg/kg Muscle Provisional MRLs expire on 1.7.2005.
550 μg/kg Skin and fat
25 μg/kg Liver
50 μg/kg Kidney
60 μg/kg Eggs
Propetamphos Sum of residues of propetamphos and desisopropyl-propetamphos OvineNot for use in animals from which milk is produced for human consumption 90 μg/kg Fat Provisional MRLs expire on 1.1.2001
90 μg/kg Kidney
2.2.5.Acyl urea derivates
Provisional MRLs expire on 1.1.2007. Not for use in animals from which milk is produced for human consumption.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Teflubenzuron Teflubenzuron Salmonidae 500 μg/kg Muscle and skin in natural proportions Provisional MRLs expire on 1 July 1999
Diflubenzuron Diflubenzuron Salmonidae 1000 μg/kg Muscle and skin in natural proportions Provisional MRLs expire on 1.7.2000
Fluazuron Fluazuron Bovine 200 μg/kg Muscle
7000 μg/kg Fat
500 μg/kg Liver
500 μg/kg Kidney
2.2.6.Pyrimidines derivatives
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Dicyclanil Sum of dicyclanil and 2,4,6-triamino-pyrimidine-5-carbonitrile Ovine 200 μg/kg Muscle Provisional MRLs expire on 1 July 2000;Not for use in animals from which milk is produced for human consumption
50 μg/kg Fat
400 μg/kg Liver
400 μg/kg Kidney
 2.2.7.Triazine derivatives
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Cyromazine Cyromazine Ovine 300 μg/kg Muscle Provisional MRLs expire on 1.7.2001Not for use in animals from which milk is produced for human consumption
300 μg/kg Fat
300 μg/kg Liver
300 μg/kg Kidney
 2.3.Agents acting against endo- and ectoparasites 2.3.1.Avermectins
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Abamectin Avermectin B1a Ovine 20 μg/kg Muscle Provisional MRLs expire on 1.1.2001
50 μg/kg Fat
25 μg/kg Liver
20 μg/kg Kidney
Doramectin Doramectin Deer, inclusing reindeer 20 μg/kg Muscle Provisional MRLs expire on 1.7.2001
100 μg/kg Fat
50 μg/kg Liver
30 μg/kg Kidney
Moxidectin Moxidectin Equidae 50 μg/kg Muscle Provisional MRLs expire on 1 January 2000
500 μg/kg Fat
100 μg/kg Liver
50 μg/kg Kidney
2.4.Agents acting against protozoa 2.4.1.Carbanilides
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Imidocarb Imidocarb Bovine, ovine 300 μg/kg Muscle Provisonal MRLs expire on 1.1.2002
50 μg/kg Fat
2000 μg/kg Liver
1500 μg/kg Kidney
50 μg/kg Milk
 2.4.2.Quinazolone derivatives
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Halofuginone Halofuginone Bovine 10 μg/kg Muscle Provisional MRL's expire on 1.1.2001
25 μg/kg Fat
30 μg/kg Liver
30 μg/kg Kidney
 2.4.3.Triazinetrione derivatives
Provisional MRLs expire on 1 July 2006. Not for use in animals from which milk is produced for human consumption.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Toltrazuril Toltrazuril sulfone Porcine 100 μg/kg Muscle Provisional MRLs expire on 1.1.2001
150 μg/kg Skin and fat
500 μg/kg Liver
250 μg/kg Kidney
Toltrazuril Toltrazuril sulfone Bovine 100 μg/kg Muscle
150 μg/kg Fat
500 μg/kg Liver
250 μg/kg Kidney
 2.4.4.Other anti-protozoal agents
Pharmacologically active substance(s) Marker residue Animal species MRL Target tissues Other provisions
Amprolium Amprolium Chicken, turkey 200 μg/kg Muscle Provisional MRLs expire on 1.1.2002
200 μg/kg Skin and fat
200 μg/kg Liver
400 μg/kg Kidney
1000 μg/kg Eggs
 2.4.5.Ionophores
Provisional MRLs expire on 1 January 2008.
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Lasalocid Lasalocid A Poultry 150 μg/kg Eggs
3.Agents acting on the nervous system 3.2.Agents acting on the autonomic nervous system 3.2.1.β 2 sympathomimetic agents
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Clenbuterol hydrochloride Clenbuterol Bovine 0,1 μg/kg Muscle Provisional MRLs expire on 1 July 2000
Indication: solely for tocolysis in parturient cows 0,5 μg/kg Liver
0,5 μg/kg Kidney
0,05 μg/kg Milk
Equidae 0,1 μg/kg Muscle
Indications: tocolysis and the treatment of respiratory ailments 0,5 μg/kg Liver
0,5 μg/kg Kidney
3.2.2.Anti-adrenergics
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Carazolol Carazolol Bovine 5 μg/kg Muscle Provisional MRLs expire on 1.1.2000
5 μg/kg Fat
15 μg/kg Liver
15 μg/kg Kidney
1 μg/kg Milk
 5.Anti-inflammatory agents 5.1.Nonsteroidal anti-inflammatory agents 5.1.1.Arylpropionic acid derivative
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Carprofen Carprofen Bovine 500 μg/kg Muscle Provisional MRLs expire on 1 January 2000
500 μg/kg Fat
1000 μg/kg Liver
1000 μg/kg Kidney
Equidae 50 μg/kg Muscle
100 μg/kg Fat
1000 μg/kg Liver
1000 μg/kg Kidney
5.1.2.Enolic acid derivates
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Meloxicam Meloxicam Bovine 25 μg/kg Muscle Provisional MRLs expire on 1 January 2000
60 μg/kg Liver
35 μg/kg Kidney
5.1.3.Pyrazolone derivatives
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Metamizole 4-Methylaminoantipyrin Bovine, porcine, equidae 200 μg/kg Muscle Provisional MRLs expire on 1.7.2003.Not for use in animals from which milk is produced for human consumption
200 μg/kg Fat
200 μg/kg Liver
200 μg/kg Kidney
 5.1.4.Sulfonated phenyl lactones
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Firocoxib Firocoxib Equidae 10 μg/kg Muscle Provisional MRLs expire on 1 July 2007
15 μg/kg Fat
60 μg/kg Liver
10 μg/kg Kidney
 6.Agents acting on the reproductive system 6.1.Progestogens
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Altrenogest Altrenogest Porcine 3 μg/kg Skin and fat Provisional MRLs expire on 1.1.2005; for zootechnical use only
3 μg/kg Liver
3 μg/kg Kidney
Equidae 3 μg/kg Fat
3 μg/kg Liver
3 μg/kg Kidney
Flugestone acetate Flugestone acetate Ovine, caprine 0,5 μg/kg Muscle Provisional MRLs expire on 1.1.2008; for therapeutic or zootechnical use only
0,5 μg/kg Fat
0,5 μg/kg Liver
0,5 μg/kg Kidney
Norgestomet Norgestomet Bovine 0,5 μg/kg Muscle Provisional MRLs expire on 1.1.2008; for therapeutic or zootechnical use only
0,5 μg/kg Fat
0,5 μg/kg Liver
0,5 μg/kg Kidney
0,15 μg/kg Milk
 7.Corticoids 7.1.Glucocorticoids
Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Methylprednisolone Methylprednisolone Bovine 10 μg/kg Muscle Provisional MRLs expire on 1.7.2001. Not for use in animals from which milk is produced for human consumption
10 μg/kg Fat
10 μg/kg Liver
10 μg/kg Kidney
 ANNEX IV LIST OF PHARMACOLOGICALLY ACTIVE SUBSTANCES FOR WHICH NO MAXIMUM LEVELS CAN BE FIXED
Pharmacologically active substance(s)
Aristolochia spp. and preparations thereof
Chloramphenicol
Chloroform
Chlorpromazine
Colchicine
Dapsone
Dimetridazole
Metronidazole
Nitrofurans (including furazolidone)
Ronidazole
 ANNEX V Information and particulars to be included in an application for the establishment of a maximum residue limit for a pharmacologically active substance used in veterinary medicinal products Administrative particulars 1Name or corporate name and permanent address of the applicant. 2Name of the veterinary medicinal product. 3Qualitative and quantitative composition in terms of active principles, with mention of the international non-proprietary name recommended by the World Health Organization, where such name exists. 4Manufacturing authorization, if any. 5Marketing authorization, if any. 6Summary of the characteristics of the veterinary medicinal product(s) prepared in accordance with Article 5a of Directive 81/851/EEC. A.Safety documentation A.0.Expert report A.1.Precise identification of the substance concerned by the application 1.1International non-proprietary name (INN).1.2International Union of Pure and Applied Chemistry (IUPAC) name.1.3Chemical Abstract Service (CAS) name.1.4Classification: therapeutic; pharmacological.1.5Synonyms and abbreviations.1.6Structural formula.1.7Molecular formula.1.8Molecular weight.1.9Degree of impurity.1.10Qualitative and quantitative composition of impurities.1.11Description of physical properties: melting point; boiling point; vapour pressure; solubility in water and organic solvents, expressed in grams per litre, with indication of temperature; density; refractive index, rotation, etc. A.2.Relevant pharmacological studies 2.1Pharmacodynamics.2.2Pharmacokinetics. A.3.Toxicological studies 3.1Single dose toxicity.3.2Repeated dose toxicity.3.3Tolerance in the target species of animal.3.4Reproductive toxicity, including teratogenicity. 3.4.1Study of the effects on reproduction.3.4.2Embryotoxicity/fetotoxicity, including teratogenicity.3.5Mutagenicity.3.6Carcinogenicity. A.4.Studies of other effects 4.1Immunotoxicity.4.2Microbiological properties of residues. 4.2.1On the human gut flora;4.2.2On the organisms and microorganisms used for industrial food-processing.4.3Observations in humans. B.Residue documentation B.0Expert report B.1.Precise identification of the substance concerned by the application The substance concerned should be identified in accordance with point A.1. However, where the application relates to one or more veterinary medicinal products, the product itself should be identified in detail, including: qualitative and quantitative composition; purity; identification of the manufacturer's batch used in the studies; relationship to the final product; specific activity and radio-purity of labelled substances; position of labelled atoms on the molecule. B.2.Residue studies 2.1Pharmacokinetics (absorption, distribution, biotransformation, excretion).2.2Depletion of residues.2.3Elaboration of maximum residue limits (MRLS). B3.Routine analytical method for the detection of residues 3.1Description of the method.3.2Validation of the method. 3.2.1specificity;3.2.2accuracy, including sensitivity;3.2.3precision;3.2.4limit of detection;3.2.5limit of quantitation;3.2.6practicability and applicability under normal laboratory conditions;3.2.7susceptibility to interference.